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Abstract
Background and Objectives: The population health care delivery model uses phenotype
algorithms in the electronic health record (EHR) system to identify patient cohorts
targeted for clinical interventions such as laboratory tests, and procedures. The standard
terminology used to identify disease cohorts may contribute to significant variation in
error rates for patient inclusion or exclusion. The United States requires EHR systems to
support two diagnosis terminologies, the International Classification of Disease (ICD)
and the Systematized Nomenclature of Medicine (SNOMED). Terminology mapping
enables the retrieval of diagnosis data using either terminology. There are no standards of
practice by which to evaluate and report the operational characteristics of ICD and
SNOMED value sets used to select patient groups for population health interventions.
Establishing a best practice for terminology selection is a step forward in ensuring that
the right patients receive the right intervention at the right time. The research question
is, “How does the diagnosis retrieval terminology (ICD vs SNOMED) and
terminology map maintenance impact population health cohorts?” Aim 1 and 2
explore this question, and Aim 3 informs practice and policy for population health
programs.
Methods
Aim 1: Quantify impact of terminology choice (ICD vs SNOMED)
ICD and SNOMED phenotype algorithms for diabetes, chronic kidney disease (CKD),
and heart failure were developed using matched sets of codes from the Value Set
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Authority Center. The performance of the diagnosis-only phenotypes was compared to
published reference standard that included diagnosis codes, laboratory results,
procedures, and medications.
Aim 2: Measure terminology maintenance impact on SNOMED cohorts
For each disease state, the performance of a single SNOMED algorithm before and after
terminology updates was evaluated in comparison to a reference standard to identify and
quantify cohort changes introduced by terminology maintenance.
Aim 3: Recommend methods for improving population health interventions
The socio-technical model for studying health information technology was used to inform
best practice for the use of population health interventions.
Results
Aim 1: ICD-10 value sets had better sensitivity than SNOMED for diabetes (.829, .662)
and CKD (.242, .225) (N=201,713, p <= .001). ICD-10 had worse specificity than
SNOMED for diabetes (.972, .975), but the same for CKD (p <= .001). Heart failure
cohorts had no significant differences between ICD and SNOMED.
Aim 2: Following terminology maintenance the SNOMED algorithm for diabetes
increased in sensitivity from (.662 to .683 (p <=0.001)). No change was observed in the
performance of CKD and heart failure algorithms. Those cohorts were unaffected.
Aim 3: Based on observed social and technical challenges to population health
programs, including and in addition to the development and measurement of phenotypes,
a practical method was proposed for population health intervention development and
reporting.
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Discussion
As a measure of overall performance, the F score for ICD phenotypes for diabetes, CKD
and heart failure equal to or better than SNOMED. Standardized testing and reporting
practices for population health algorithms will inform local and national practice for
management of population health cohorts.
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Key Terms
Coding System

Any terminological system that uses codes for designating concepts.
(de Keizer, Abu-Hanna, & Zwetsloot-Schonk, 2000)

Cohort

Any designated group followed or traced over a period of time.
(cohort)

Classification

A classification uses more general “is-member-of” relationship.
(de Keizer et al., 2000)

Gold standard

Gold standard refers to the method by which a reference standard is
generated by two or more independent reviewers with adjudication
to obtain agreement.

Highthroughput
clinical
phenotyping

High-throughput clinical phenotyping executes an algorithm against
already existing data within an EHR system to rapidly obtain a large
pool of eligible study subjects. (Wei et al., 2012)

Phenotyping

Phenotyping is the action of applying an algorithm to select a cohort
within an EHR system for a defined purpose, including case–control
cohorts for genome-wide association studies, clinical trials, quality
metrics, and clinical decision support. (Pathak et al., 2013)

Population
health

Use of the EHR system to identify patient cohorts in need of
evidence-based interventions, and to facilitate action to address care
gaps.

Population
health registry

An EHR-based registry for the purpose of driving clinical
interventions is also called a population health registry. This
registry subtype identifies care gaps and triggers bulk ordering and
secure bulk messaging as well as clinic outreach phone calls.
(Berkovich, 2016); (Sitapati, 2016)

Reference
standard

A reference standard is the list of positive and negative case findings
against which the performance of a phenotype algorithm is
evaluated. Manual generation of a reference standard can be grouped
into three levels: Gold standard, Trained standard and Regular
practice. (Stanfill, Williams, Fenton, Jenders, & Hersh, 2010)
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Automated forms of developing reference standards show promise.
(Agarwal et al. (2016)
Terminology

A list of terms related to concepts is a “terminology”. In this sense,
both ICD and SNOMED CT® are terminologies in the domain of
clinical findings and diagnoses.

Thesaurus

An ordered terminology that includes synonyms
(de Keizer et al., 2000)

Value Set

Numerical values (codes) and human-readable names (terms), drawn
from standard vocabularies such as SNOMED CT® , RxNorm,
LOINC and ICD-10-CM, which are used to define clinical concepts.
For example, a value set may contain any number of codes across
terminologies that represent a clinical concept such as a patient with
myocardial infarction. These clinical concepts can then be used in
constructing algorithms for quality measures, or population health
identification rules. (U.S. National Library of Medicine)

Vocabulary

Terminology or Thesaurus that includes concept definitions.
(de Keizer et al., 2000)
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Chapter 1: Introduction
The goal of population health programs for chronic care is to improve the quality and
while reducing unnecessary utilization such as emergency visits and hospitalizations
(Altavela, Dorward, Sorrento, Diehl, & Wyman, 2017). Chronic disease management
aims to avert morbidity and prioritize clinical interventions that can reduce risk for poor
outcomes (McClatchey, 2001). Population health registries are a pivotal tool to support
the delivery of this kind of evidence-based care (Lyon & Slawson, 2011). The clinicians
using population health registries depend on accurate groups, or cohorts of individuals
who share a characteristic and who are then followed forward in time. Grouping patients,
with diabetes for example, is a phenotyping task which is conceptualized in Figure 1.

Figure 1. Disease phenotyping with standard terminologies
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Diagnostic terms and their associated codes are applied to the patient records in the
problem list, encounter diagnoses, and other locations within the EHR system depending
on the nature and setting of the patient care. A phenotyping algorithm uses diagnosis
codes to separate patients into cohorts, those with the specific code(s) associated with
them. The algorithm matches patient diagnosis codes from the EHR data to a value set of
codes that define a disease concept in a standard medical terminology. The International
Classification of Diseases (ICD) and the Systematized Nomenclature of Medicine –
Clinical Terms (SNOMED CT) are two of these terminologies. Both have mandates
requiring their support in certified EHR systems. When a cohort is selected from a pool
of patients, one way of measuring the accuracy of the assignment to a disease group is by
comparing each patient in the cohort to a reference standard of patients known to have
the disease.
Terminology maps allow patients to be identified for diagnosis groups using either ICD
or SNOMED values sets. As terminologies evolve, the maps must be maintained to
incorporate new codes or remove codes that are no longer in use.
The research question is, “How does the value set terminology (ICD vs SNOMED)
and terminology map maintenance impact population health registries?”
Specific Aim 1 Quantify impact of terminology choice (ICD vs SNOMED)
Specific Aim 2 Measure the impact of terminology maintenance on SNOMED
cohorts
Specific Aim 3 Recommend methods for improving population health
interventions
2

This research will evaluate key risks related to terminology mapping as well as possible
approaches to improve the visibility of terminology shifts that occur over time and
mapping changes in the EHR that apply those terminology changes to the system.
1.1 Population Health in Practice
The Health Information Technology for Economic and Clinical Health (HITECH) Act of
2009 gave legislative authority to CMS to develop quality measures to help drive the
development and the adoption of health information technologies. Since then, the number
of incentivized quality measures at local, state and national levels has continued to
increase. In addition to the Merit-based Incentive Payment System (MIPS) and Advanced
Alternative Payment Models (APMs), CMS 1115(a) demonstration waivers are
designating billions of dollars to states for Medicaid reform, a large portion of which will
be tied to quality indicators. California’s five-year Medi-Cal 2020 Demonstration
program includes $6.2 billion of initial federal funding to transform and improve
the quality of care, access, and efficiency of health care services for 12.8 million member
(Mcleod, 2016). Roughly half of this sum is allocated to Public Hospital Redesign and
Incentives in Medi-Cal (PRIME) which offers incentives public hospitals for
performance measures for quality and efficiency. As value-based care models create a
financial imperative in many organizations to qualify for government quality incentives,
and benefit from shared risk programs, pressure to “meet the measures” is intensifying. In
this environment, population health has become a preferred care delivery paradigm to
drive health care quality and quality measures.
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The Agency for Healthcare Research and Quality (AHRQ) National Measures
Clearinghouse maintains a broad set of quality measures sponsored by diverse
organizations that cover many disease states. Healthcare providers demonstrate their
adherence to evidence-based guidelines through a suite of quality measures. Table 1
provides examples of Meaningful Use quality measures for diabetes (eCQM 122-Percent
of patients with hemoglobin A1C (HbA1C) levels > 9%, and 134- Percent of patients with
a screening for nephropathy), End Stage Renal Disease (Percent of patients with mean
hemoglobin value greater than 12 g/dL), and heart failure (eCQM 135-Percent of
Patients with heart failure (Left ventricular ejection fraction LVEF < 40%) who were
prescribed ACE inhibitor or ARB therapy).
Population health tools embedded within the EHR continue to be developed and refined
to ensure that evidence-based interventions for chronic care management are routinely
and reliably provided to patients as demonstrated by quality performance measures.
Errors in the patient groups may negatively impact the quality and efficiency of patient
care. The risk and cost of discovery errors (false positives) and omission errors (false
negatives) are determined by the type of intervention and the number of patients in the
population served. Table 1 also provides examples of the possible impact of discovery
and omission errors. For patients in chronic care management programs, discovery errors
may result in unnecessary messages and lab orders, wasted outreach costs, and possible
drug-drug interactions. For these same groups of patients, omission errors may increase
the risk and cost of disease complications, and put patients at higher risk of death.
Misattribution of patients to population health cohorts may lower performance on quality
measures as well, because the indicated interventions are not appropriate.
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Table 1. Meaningful Use quality measures for diabetes, end-stage renal disease and
heart failure

Meaningful Use Quality Measures

Discovery Error
(False Positive)

Omission Error
(False Negative)

Diabetes

HbA1c level > 9.0%

Unnecessary
messages and
lab orders

Increased risk/cost of
complications

End-stage
renal
disease

Mean hemoglobin value
greater than 12g/dL

Wasted outreach

Miss patients and put at
higher risk of death

Heart
failure

Heart failure
(LVEF < 40%) who
were prescribed ACE
inhibitor or ARB
therapy

Possible
adverse drug
reactions

Increased risk of death
or re-admission

The Centers for Disease Control and Prevention (2017) estimates 23 million adults in the
U.S. have a diagnosis of diabetes. Small errors in discovery or omission of patients in a
chronic disease cohort are magnified when applied across a large population. In quality
reporting a 1% error rate may be well within acceptable limits. However, when applied
to actual clinical interventions, a false omission rate of 1% in a population of 23 million
could put over 200,000 patients at risk for missing diabetes follow-up care. At that same
rate of error, false discovery may cause another 200,000 to be targeted for diabetes
interventions that were not appropriate.
5

The cost of treatment increases dramatically as patients move from a single disease state
to multiple chronic diseases. The United States Renal Data System (2016) reports a
2014 fee-for-service expenditure of $254.4 billion on Medicare beneficiaries age 65 and
older with diabetes, CKD and/or heart failure. The breakdown by disease category in
Table 2 identifies 5.9 million beneficiaries with diabetes (with or without CKD and/or
heart failure) comprising 24.02% of the Medicare population and utilizing 35.12% of the
costs. The per person per year (PPPY) cost for diabetes alone ($12,116) increases
significantly when diabetes is treated with CKD and/or heart disease ($16,003). As a
percentage of the beneficiary population, CKD (10.77%) and heart failure (8.89%) utilize
double the percentage of total budget than their numbers would suggest (CKD 20.77%,
heart failure 20.60%). The goal of population health programs is to identify and manage
chronic disease to keep patients healthier and reduce the burden of these diseases on the
health system.

Table 2. Medicare spending for beneficiaries aged 65 and older 2014

Medicare
Population Cost
Count
%
%

PPPY Cost
1 Condition

PPPY Cost
Total
2 or more
Costs
Conditions (millions)

All Diabetes

5.9 m

24.02

35.12

$12,116

$16,003

$89,327

All CKD

2.6 m

10.77

20.77

$15,673

$21,857

$52,819

All Heart failure

2.1 m

8.89

20.60

$20,733

$26,975

$52,409

6

Note. The data reported here have been supplied by the United States Renal Data System (USRDS).
The interpretation and reporting of these data are the responsibility of the author(s) and in no way
should be seen as an official policy or interpretation of the U.S. government.

1.2 Population Health Registries
Within a health system, population health programs utilize registries to ensure that
patients sharing a common chronic disease receive the standard of care defined in an
evidence-based protocol (Drawz et al., 2015). Regardless of etiology, chronic care
management programs face the common challenge of monitoring a cohort of patients to
ensure they are reevaluated at regular intervals, and that treatments are effective based on
quantitative measures. The use of registries enables the identification of a group of
patients at risk for multiple adverse outcomes, and creates the opportunity for efficient
and directed intervention when there is a care gap between the patient’s current treatment
state and the protocol. A population health registry integrally embedded in an EHR
system enables bulk orders, and secure bulk messaging via the EHR patient portal
(Berkovich, 2016; Sitapati, 2016). Due to the very real impact on human resources,
patients, and payers, inclusion in these registries requires the same high level of accuracy
that has typically been associated with clinical decision support.
1.3 History of ICD and SNOMED
Both ICD and SNOMED CT® are standard medical terminologies in the domain of
clinical findings and diagnoses. They support the input and retrieval of information from
a clinical system (Brown & Sonksen, 2000). ICD codes have long been used by CMS to
process claims for hospitals, clinics, and other professional services. In 2016, $366 billion
in healthcare reimbursements was processed using ICD-10-CM codes to define the
diagnoses covered by the Medicare Fee for Service Program (Centers for Medicare &
7

Medicaid Services (CMS), 2016). The Code of Federal Regulations 45 CFR 162.1002
designates ICD-10-CM as the medical data code set for medical problems for the period
on or after October 1, 2015 (Code of Federal Regulations (annual edition), 2015). The
Department of Health and Human Services maintains and distributes ICD-10-CM for the
following conditions: (i) Diseases, (ii) Injuries; (iii) Impairments; (iv) Other health
problems and their manifestations. (v) Causes of injury, disease, impairment, or other
health problems (Code of Federal Regulations (annual edition), 2015).
Bowman (2005), Director of Coding Policy and Compliance for the American Health
Information Management Association (AHIMA), described ICD as a “Classification
system” that functions optimally for aggregating patient groups for claims processing and
quality programs outputs. Classification systems were not intended or designed as the
primary documentation for clinical care, yet they are the most common source of clinical
data today, due to their necessity for claims processing (Bowman, 2005). The
terminology has developed into an international standard for diagnostic classification in
epidemiology, health management and clinical purposes (Fung & Xu, 2012).
From its inception, the necessity of revision based on scientific discovery was
recognized, with the original ICD update cycle set at 10 years. ICD-9 was introduced to
the public domain in 1977, formatted with 4-digit categories and optional 5 digit
subdivisions (Hirsch et al., 2016). ICD-9-Clinical Modification (CM) was the U.S.
extension developed by the National Center for Health Statistics to support diagnostic
coding in the inpatient and outpatient settings (Hirsch et al., 2016). ICD-10 was first
published in 1992 (World Health Organization). Figure 2 illustrates the differences
between ICD-9 and 10 code formats.
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Figure 2. Sample of ICD-9-CM and ICD-10-CM billing codes

SNOMED CT® is also legislated for use in U.S. EHR systems as a vocabulary standard
for representing electronic health information about medical problems per 45 CFR
170.207 (Code of Federal Regulations (annual edition), 2015). The International Health
Terminology Standards Development Organization (IHTSDO) maintains and distributes
SNOMED CT® “to facilitate the accurate recording and sharing of clinical and related
health information and the semantic interoperability of health records” (Randorff Hojen
& Kuropatwa, 2014). SNOMED CT® is considered the most comprehensive,
multilingual clinical terminology in the world (Fung & Xu, 2012). It has a
polyhierarchical logic model, and serves as a thesaurus, nomenclature, taxonomy,
ontology, and coding system of clinical concepts (Saitwal et al., 2012). Despite these
advantages for clinical documentation, SNOMED’s size, complex hierarchies and lack of
reporting rules render it impractical for patient reimbursement and regulatory reporting
9

(Bowman, 2005). A survey of EHR vendors by Giannangelo and Fenton (2008) found a
lack of incentives or drivers in the industry was a barrier to SNOMED CT
implementation within their products. Subsequent legislation mandating the use of
SNOMED CT in EHR systems, and the selection of SNOMED as the reporting
terminology for the CMS Merit-based Incentive Payment System (MIPS) have
introduced these drivers and incentives into the industry. A 2013 article in the Journal of
Biomedical Informatics finds that although it is reported to be used in over 50 countries,
there is still much work ahead to bring SNOMED CT into routine clinical use (Lee,
Cornet, Lau, & De Keizer, 2013). Quality challenges reported by this study included
content coverage, hierarchical relationships, ambiguity of terms and syntactic
consistency.
Bowman (2005) describes SNOMED-CT® as a “Reference terminology” designed to
codify clinical information captured in an EHR during the course of patient care. As an
input terminology, the semantic and contextual meanings of the clinical terms are
paramount. The conceptual diagram of a SNOMED concept browser in Figure 3
illustrates that concepts exist within a hierarchy of parent-child relationships. For
example, SNOMED concept 84114007 Heart Failure has a parent concept called
Disorder of cardiac function and 26 child concepts including Acute Heart Failure
56675007, Cardiorenal syndrome 445236007, and Chronic heart failure 48447003.
SNOMED CT concept hierarchies support retrieval of diagnosis data at various levels of
granularity, and one SNOMED concept may be mapped to just one, or potentially
thousands of ICD codes.
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Figure 3. Conceptual diagram of a SNOMED CT® concept browser

The Journal of the American Medical Informatics Association (JAMIA) reported how
three professional coding companies applied SNOMED concepts to the same clinical
findings (Andrews, Richesson, & Krischer, 2007). In this small study, SNOMED codes
for a vascular exam were selected to describe the finding, body structure and a qualifier.
No significant correlation was found between the assigned codes. In fact, all three agreed
on the core concept only 33% of the time, and 23% of the time there was no agreement at
all, Andrews et al. (2007) raise the question, if coders can’t agree on how to code a
finding, what impact will that have on the retrieval?
1.4 Cross-terminology Mapping
Cross-terminology mapping in the EHR is essential because there is no single diagnosis
terminology standard (Foley, Hall, Perron, & D Andrea, 2007). A 2005 White Paper by
the American Health Information Management Association (AHIMA) described how
ICD and SNOMED should be used together with mapping linking the two (Bowman,
2005). Figure 4 is an adaptation of the terminology mapping concept by which the
SNOMED reference terminology is the input for clinical terms, and ICD is the output
11

classification system used for claims processing and quality reporting (Bowman, 2005).
A terminology map is sometimes referred to as a crosswalk, implying a 1 to 1
relationship. In fact, because terminologies have different structures and intended uses,
relationships can be: 1 to many; many to 1; many to many; or complex. Hussain et al.
(2014) describe how erroneous mapping can be unintentionally created when two
unrelated concepts (A1 and A2) are mapped to common concept (B). Although this logic
applies in algebraic relationships (If A1 = B and A2 = B, then A1 = A2), this construct
does not always hold up when applied to hierarchical terminological constructs. It is also
incorrect to assume that if A1 equals B that all dependents of A1 in a hierarchical concept
tree also equal B. Reich, Ryan, Stang, and Rocca (2012) describe cases where no
mapping is possible such as when a code does not have a corresponding code in the
destination terminology. The size and structure of the ICD and SNOMED terminologies
present significant challenges to those creating and maintaining terminology maps (Boyd
et al., 2015).
In the era of paper medical records, a workforce of coders was responsible for applying
billing codes based on free text evidence in the health record. In EHR systems of today
clinicians routinely perform a text search that returns a list of possible diagnosis terms
from which one is selected to be applied to the patient record.

12

Figure 4. Conceptual diagram of terminology mapping (adapted from Bowman, S. E.,
2005).

A conceptual diagram of the application of diagnosis codes to patient records is in Figure
5. The clinician selects one of many clinical terms supplied by the third party
terminology vendor. The local diagnosis code associated with the selected term is
applied to the patient problem list or encounter diagnosis. The code mappings link the
local codes to the standard terminologies, ICD and SNOMED.
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Figure 5. Conceptual diagram of the application of diagnosis codes to patient records

Intelligent Medical Objects, Inc. (IMO®) offers a terminology solution that maps medical
terms commonly used by clinicians to ICD and SNOMED. Epic, Cerner, NextGen, and
several other EHR systems incorporate IMO terms in their software. (Kottke & Baechler,
2013) Apelon Distributed Terminology System (DTS) is an open source solution. As a
licensee of IHTSDO, the U.S. National Library of Medicine (NLM) is the single public
source of SNOMED CT data in the United States (U.S. National Library of Medicine,
2011). The internal mapping relationships between local and standard diagnosis
terminologies support the output, retrieval and aggregation of patient cohorts using ICD9-CM, ICD-10-CM or SNOMED CT (Figure 6). Terminology middle-ware functions as
an interface terminology employing internal mappings to shield users from the need to
assign standard terminologies such as ICD and SNOMED codes directly. A survey of
SNOMED users found, “In most cases SNOMED CT had been so seamlessly integrated
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that that users were unaware that they were using SNOMED CT through and interface
terminology,” (Lee et al., 2013).

Figure 6. Conceptual diagram of terminology mapping circa 2017
Challenges encountered when mapping International Classification for Nursing Practice
(ICNP) to SNOMED-CT included inconsistencies, redundancies, and deficiencies of
SNOMED CT concepts (Kim, 2016). The consequence of attendant errors are
acknowledged in the American Health Information Management Association publication,
Data Mapping and its Impact on Data Integrity.
…poorly designed or out-of-date mappings create significant data integrity
problems in health information systems. Undetected errors in data maps have the
potential to introduce many problems including the filing of false claims to
insurers, delivering the wrong information for patient care and/or quality
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measures, or causing a breach in patient privacy (Hyde, Rihanek, SantanaJohnson, & al, 2013).
The most serious problems may actually derive from delivery of the wrong care to a
patient or the failure to deliver intended interventions.
1.5 Maintenance of Terminologies and Maps
Terminology maintenance is a necessary and expected activity in the domain of health
information technology (HIT) due to rapid evolution of the evidence base, regulation,
clinical and administrative practices (Cimino, Clayton, Hripcsak, & Johnson, 1994).
Saitwal et al. (2012) state “… all mappings must be maintained and updated as errors
are found and corrected, and as the source and target terminologies change.”
Terminology updates and correlated cross-terminology mapping revisions occur in all
modern EHR systems, and yet there is no standardized way to identify and measure the
impact of this activity on downstream uses of the diagnosis codes. Even when a crossterminology map has demonstrated good performance, it must be maintained to stay
current if concepts and terms are added, removed, or the meaning of a code changes, so
as to continue to produce consistent results (Rea et al., 2012). Codes may also be
deprecated, meaning they are no longer active to be newly applied to patient records, but
remain in the EHR for backward compatibility. An important finding by the Strategic
Health IT Advanced Research Projects Area 4 Consortium is that, “The SHARPn
demonstration did not deal with multiple versions of terminologies or updates to
terminologies, but it became apparent that any robust data normalization effort will need
to do so,” (Rea et al., 2012).

16

When the U.S. transitioned from ICD-9 to ICD-10 for cause of death reporting, the CDC
provided preliminary comparability ratios to indicate the extent of discontinuities
resulting from the coding changes (Anderson, Miniño, Hoyert, & Rosenberg, 2001).
Bridge-coding studies are designed to measure the effects of new terminology revisions
using duel coded datasets. According to Fenton and Benigni (2014), “Longitudinal data
comparisons can only be reliable if they use comparability ratios or factors which have
been calculated using records coded in both classification systems.” However, it’s
important to recognize that the comparability statistic only describes the net change in the
resulting cohorts, and thus lacks detail as to which patients were added and deleted as a
result of the terminology changes. Figure 7 illustrates various methods for evaluating
shifts caused by terminology mapping. Comparison of the overlap of terms only as in
diagram A will provide an indication of the terms added and dropped from a phenotype
definition due to terminology mapping, but the effect of those changes on the patient
population depends on the prevalence of the codes, and can therefore not be established
by this method. Diagram B shows the method of instantiation whereby the mapping
difference may be stated by comparing the cohorts of disease positive patients found by
each diagnosis terminology. A drawback of this method is that although the difference
can be ascertained, there is no way to determine if the change is better or worse. The
method in diagram C uses a reference standard as a common comparator from which to
find true positives and establish a rate of error. Comparison of the phenotype
performance to the reference standard provides a quantitative method by which to
establish which terminology performs better.
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Figure 7. Evaluating the difference between diagnosis terminologies

Fluctuations of membership in a population health CKD registry have been observed
following terminology updates to the EHR system. The January 28-31, 2016 EHR
terminology map maintenance at a university health system that applied SNOMED
updates to the EHR system resulted in the decrease of the CKD registry population by
2,065 patients, roughly one third of its members. This unexpected change was caused
when the EHR internal mapping from ICD-9-CM 585 Chronic Kidney Disease (CKD) to
SNOMED 433146000 Chronic kidney disease stage 5 was inactivated. A data integrity
process monitoring the number of patients in this registry identified the unintended
consequence of this update, and the problem was resolved by changing the inclusion rule
to ICD-10-CM coding exclusively.
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Due to the size and complexity of the current clinical terminologies, maps are likely to
have some errors. Terminology maintenance creates a dynamic setting in which the
adjustment of a map or the failure to do so may introduce errors into the phenotype
algorithms that rely on mappings. This effect was reported when ICD-9-CM diagnosis
codes for acute liver failure were mapped from ICD to SNOMED CT (Reich et al., 2012).
The acute renal failure cohort was less than 10 patients, and the resulting shift of 1 patient
was too small to detect the true rate of change.
1.6 Registry Membership is a Phenotyping Task
In order to measure the properties of a phenotype algorithm, the true state of each patient
must be established using a reference standard. The generalized 2 X 2 contingency table
with experimental results True positive, False Positive, True Negative, and False
Negative can be used to calculate a number of additional summary statistics (Table 3).
Sensitivity, specificity, and positive predictive values (PPV) are commonly reported
measures of phenotype performance. When selecting the best version of a phenotype
algorithm, there is typically a trade-off between finding all of the patients expected to
benefit from an intervention and excluding patients who won’t benefit or may be harmed
by an intervention. The false discovery rate (FDR) and the false omission rate (FOR) are
of particular concern because these statistics predict the number of patients
inappropriately included or exclude from intervention group in error. The review of the
literature provided deeper insight into the use of these statistics in the phenotyping
literature.
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Table 3. Summary statistics derived from a 2 X 2 contingency table
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Chapter 2: Literature Review
A PubMed literature review was conducted May 11-22, 2016 with the help of a research
librarian at the University of California, San Diego (Mary Wickline). The search strategy
was designed to target articles about electronic phenotype studies (ICD or SNOMED) for
diabetes, CKD or heart disease (Figure 8). The final combination of search terms yielded
222 abstracts that were evaluated on the following inclusion criteria:


data source is observational clinical data and coding terminology is ICD-9-CM,
ICD-10-CM or SNOMED-CT



diagnosis phenotype accuracy is reported



use case was chronic disease management or quality measures for diabetes,
CKD, or heart disease



article in English and full text available

The full text articles meeting the criteria (91) were coded for references to ICD and
SNOMED terminologies (54 unique articles), electronic phenotyping methods (61
unique articles) and disease classification (44 unique articles). Appendix A contains
the details of the search terms.
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Figure 8. Literature search strategy
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2.1 Current Uses of ICD and SNOMED Medical Terminologies
The articles about ICD and SNOMED were reviewed to glean information on the
frequency and context of the diagnosis coding options. Of these 54 articles, 49 (74%)
used ICD-9-CM, 12 (22%) used SNOMED CT and 6 (11%) used ICD-10-CM. Several
articles compared terminologies, and included more than one.
ICD-9-CM was primarily developed for billing and administrative applications and does
not necessarily imply a well-defined robust and logical hierarchy for the codes. (Pathak,
Kiefer, Bielinski, & Chute, 2012) However, clinical researchers often use ICD billing
diagnosis codes for phenotyping because these codes are mandated for payment within
the U.S. healthcare system, and the disease, signs and symptoms in ICD terms are often
used as a surrogate for the disease phenotype (Pathak et al., 2013); (Schildcrout et al.,
2010). ICD-9 was used as a primary phenotype rule in studies diabetes, (Fort, Wilcox, &
Weng, 2014) (Klompas et al., 2013) (Meyers, Candrilli, & Kovacs, 2011) (Nag et al.,
2007) (Wilke et al., 2007) (Zhong et al., 2016) kidney disease (Ferris et al., 2009[
[Brieler, 2016 #1397) (Navaneethan et al., 2011) (Murff et al., 2011) (Cipparone et al.,
2015) and heart disease (Baker et al., 2007) (Broberg et al., 2015) (Floyd, Blondon,
Moore, Boyko, & Smith, 2016) (Kleinberg & Elhadad, 2013) (Hoang et al., 2014) (Udris
et al., 2001) These articles, dated 2001-2016 use relatively simple ICD-9 algorithms,
using the character X to denote a place holder for any digit, for example “Diabetes
250.X0, 250.X2” (Brieler, Lustman, Scherrer, Salas, & Schneider, 2016; Broberg et al.,
2015); (Andrade et al., 2011).
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Recent adoption of ICD-10-CM in October 2015 helps explain the low number of articles
retrieved in May of 2016 as compared to ICD-9-CM and SNOMED. The mandated
coding standard had yet to be fully explored in the literature at the time of the search.
Canada adopted ICD-10 in 2001, well before the United States. So, Evans, and Quan
(2006) compared the performance of ICD-9 and ICD-10 in the retrieval of nine AMI
comorbidities, and found similar sensitivity, specificity, positive predictive value and
negative predictive value. This study included 193 patients with known AMI as
confirmed by chart review, and also considered prevalence and mortality in a Canadian
province from 1994-2004. So et al. (2006) concluded that ICD-10 coding algorithms
performed similarly to ICD-9. Although ICD-10 was first published over a decade ago,
the ICD-10-CM U.S. extension has over 3 times the codes of its ICD-10 parent
terminology. It will take time to collect longitudinal ICD-10-CM data, and to develop and
validate new ICD-10-CM coding algorithms.
SNOMED CT has an ontological structure that was more frequently correlated with
natural language processing phenotyping. de Keizer et al. (2000) define an ontology as “a
specification of concepts, relations and functions for a domain”. The relations convey
lexical relationships (shared meaning) between terms that are semantically different, for
example “kidney disease” and “renal failure”. Liaw et al. (2014) conclude that integrating
multiple data elements with an EHR using ontology-based case-finding algorithms can
improve the accuracy of a Type 2 Diabetes Mellitus registry. SNOMED CT-AU was the
domain ontology used in this Australian study. Although it’s true that data fragmentation
and inaccuracy can negatively impact the quality of phenotype results, (Wei, Leibson,
Ransom, Kho, & Chute, 2013) (Jolly et al., 2014) the Liaw study does not separate the
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effects the ontology versus the effects of the inclusion of additional discrete items in a
discrete rule-based approach.
A case has been made that SNOMED© CT simplifies querying of clinical data to the
extent that knowledge of clinical medicine, coding schemes and database structure is no
longer required (Lieberman, Ricciardi, Masarie, & Spackman, 2003). It may seem so
when myocardial infarction, coronary artery disease, heart failure and hypertension can
each be mapped to a single SNOMED concept. This study was conducted without the use
of a reference standard, and ICD-9 codes were assumed to designate the “true” state. The
reported Recall rate for Type II Diabetes Mellitus was 0.987 and Heart Failure was 0.921.
However, lack of detail about the methods of SNOMED mapping and failure to compare
against a reference standard lead to questions about the reproducibility of the results. A
concerning finding was that the concept of ‘insulin dependent diabetes mellitus’ was not
included under the type I diabetes hierarchy in SNOMED which explained the recall rate
of 0.741 for Type I Diabetes Mellitus (Lieberman et al., 2003). It is precisely these types
of mapping decisions that must be studied across a wide range of disease states.
Ultimately, the use of SNOMED CT in CMS quality programs will likely be the most
significant driver of adoption. The Meaningful Use Stage 2 rule identifies SNOMED CT
as a clinical terminology standard of certified EHR systems. Therefore, it is critical to
understand the principles and implications of using SNOMED CT and other clinical
standards for knowledge representation within EHR systems (Monsen et al., 2014).
2.2 Electronic Phenotyping Methods
The review of 61 articles on phenotyping methods revealed that a nearly three quarters
(74%) used discrete data, as compared to free text data (18%) or hybrid techniques (8%).
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Some argue that a gold standard is required to evaluate the retrieval performance of a
terminology (Brown & Sonksen, 2000). Rubbo, Fitzpatrick, Denaxas and colleagues
contend that a major problem in evaluating studies of EHR-derived diagnoses is the
implementation of a "gold standard" (Rubbo et al., 2015). The method is time intensive,
and depending on the use case, some suggest that any baseline standard will suffice as a
comparator (Agarwal et al., 2016). Agarwal, Podchiyska, Banda and colleagues are
among the growing number of researchers who are developing improved automation for
the creation of gold standards from clinical sources, and they have found value in the use
of a semi-automated “silver standard” for labeling training sets for phenotype models.
Stanfill et al. (2010) reported, literature evaluating automated coding and classification
systems only reports this step in approximately 50% of studies comparing performance of
a coding terminology to a gold standard.
To achieve the high levels of accuracy required to drive prospective chronic disease care,
population health registries must look beyond the readily available discrete diagnosis
codes, and include diagnosis, lab values, procedure results, and so on (Wei et al., 2016).
Since population health interventions trigger actionable intervention on real patients, the
registry inclusion rule (functioning as a phenotype algorithm) routinely filters out
deceased patients and those with no medical visits or acute care in the last 3 years.
Active patients are grouped according to diagnoses for chronic disease management.
Navaneethan and colleagues from Cleveland Clinic implemented an EHR-based CKD
registry using an inclusion rule based on one face-to-face encounter, two encounter
diagnoses for CKD, and/or two estimated (eGFR) values indicating CKD stage 5 or
higher (Navaneethan et al., 2011). The CKD inclusion rule was approved following a
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chart review of 20 randomly selected charts by three reviewers, and the resulting registry
of over 57,000 patients has become a valuable research for tool for studying CKD
comorbidities (Navaneethan et al., 2011).
Studies using discrete data most frequently reported sensitivity, specificity, and positive
predictive value (PPV). Data mining techniques reported precision and recall. Despite the
different naming conventions precision and recall formulas are the same as PPV and
sensitivity. These two statistics were reported by more than 50% of the articles and
specificity by about 30%. Other statistics were reported less than 20% of the time
including; negative predictive value, 2 x 2 contingency table (or text equivalent),
accuracy, area under the curve (AUC), receiver operating curve (ROC), Chi square, and
percent match (Figure 9). Overall, there was little consistency in the published evaluation
methods or performance measurements for phenotypes. Appendix B Electronic
Phenotyping Evaluaton Methods lists the reviewed articles referencing each statistic.

Figure 9. Statistical methods used in 61 phenotyping articles from literature search

27

Reich et al. (2012) explored the impact of terminology changes on queries of the
Observational Medical Outcomes Partnership research network data. Reich’s results
clearly show the number of patient records lost or gained as compared to the original
ICD-9-CM cohort when mapped to SNOMED and MedDRA definitions. Of course,
inclusion of the 2x2 contingency table in published results would support the calculation
of all the summary statistics listed in Table 5 including Sensitivity, Specificity, and PPV,
but only 15% of the articles provided this information. True Positive, False Positive, True
Negative, and False Negative values provide valuable information even when presented
in non-standard formats. Garvin et al. (2013) reported these values in a single table
combined with sensitivity, specificity and PPV.
2.3 Disease classification for Diabetes, Chronic Kidney Disease and Heart Failure
My review of the literature found additional information about the significance and
interrelatedness of diabetes, CKD and heart failure. Of the 44 phenotype articles
mentioning a disease condition of interest, diabetes was by far the most heavily reported
(30, 68%) followed by CKD (12, 27%) and heart failure (9, 20%).
Diabetes has been rapidly increasing in prevalence in recent years. CDC estimates 1.7
million new adult cases of Type 2 diabetes are diagnosed each year (Centers for Disease
Control and Prevention, 2015). If the trend continues 438 million adults are estimated to
develop diabetes by the year 2030 (Pathak et al., 2012; Rathmann W & Giani G, 2004).
Type 2 diabetes accounts for 90-95% of all new diabetes cases in the U.S. People with
diabetes typically experience healthcare costs 2.3 times higher than non-diabetics.
Approximately 40% of CKD cases are attributable to diabetes (Huopaniemi et al., 2014;
Meyers et al., 2011; Nadkarni et al., 2014). The prevalence of CKD in the U.S. is
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estimated to be 13% (Navaneethan et al., 2011). CKD is a precursor to End Stage Renal
Disease (ESRD) that warrants dialysis or transplantation (Navaneethan et al., 2013;
Schroeder et al., 2015). Even small degrees of renal impairment are associated with
increased cardiovascular disease risk, cardiovascular mortality, and health care costs. The
status of kidney function is based upon a calculation that includes a laboratory value from
routine metabolic profile called serum creatinine. This value is used in the calculation of
eGFR which is used to assess the severity of the condition (Levey & Coresh, 2012).
Table 4 shows the eGFR ranges for Chronic Kidney Disease Stages 1 through 5. Stage 5
is the most severe kidney disease which can only be treated by dialysis or transplantation,
and is also known as End Stage Renal Disease (ESRD). Note that ESRD is often equated
with and typically commences in Stage 5, but only refers to patients starting or receiving
dialysis or transplantation (United States Renal Data System, 2017).

Table 4. Chronic Kidney Disease staging 2014 USRDS Annual Data Report
Stage 1

eGFR ≥ 90 mL/min per 1.73 m²

Stage 2

eGFR 60–89 mL/min per 1.73 m²

Stage 3

eGFR 30–59 mL/min per 1.73 m²

Stage 4

eGFR 15–29 mL/min per 1.73 m²

Stage 5

eGFR < 15 mL/min per 1.73 m²

Heart failure causes shortness of breath, weight gain and tiredness when the heart is
unable to supply sufficient blood flow to the body. The primary diagnostic test is cardiac
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ejection fraction also known as Left Ventricular Ejection Fraction (Bielinski et al., 2014).
A LVEF measure less than 40 is the established clinical definition of heart failure which
can be either chronic or acute. Agarwal et al. (2016) warns that guidelines and quality
measures for heart failure will need to account for multiple measures of LVEF that may
change over time, with a patient moving across the threshold for heart failure in both
directions. About half of the people who develop heart failure die within 5 years of
diagnosis. (Mozaffarian D et al.)
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Chapter 3: Aim 1. Quantify impact of terminology choice (ICD vs SNOMED)
3.1 Introduction
The statistical analysis of sensitivity and specificity is dependent on the population, and
cannot be assumed to be consistent across multiple EHR instances or disease states. It is
therefore fundamental to establish a methodology by which the retrieval properties of a
phenotype rule are established locally to inform clinical and financial decision making.
Terminology maps supplied by third-party middleware providers enable rule-based
retrieval of patient diagnoses coded in ICD and SNOMED terminology. The Value Set
Authority Center (VSAC) provided matched sets of chronic disease value sets coded in
ICD and SNOMED which were used to isolate the effect of terminology choice in the
retrieval of diabetes, CKD and heart disease. As a licensee of IHTSDO, the U.S. National
Library of Medicine (NLM) is the single public source of SNOMED CT data in the
United States (U.S. National Library of Medicine, 2011). VSAC is the repository for
official versions of diagnosis value sets for regulatory quality programs such as
Meaningful Use and Clinical Quality Measures. The value sets are maintained by the
National Library of Medicine (NLM), in collaboration with the Office of the National
Coordinator for Health Information Technology (ONC) and CMS (Bodenreider et al.,
2013). When the VSAC value sets are used in a phenotype algorithm, the selection of a
patient cohort is like a binomial diagnostic test, rendering a positive or negative result for
each disease state. When both ICD and SNOMED phenotype algorithms “test” the same
patient population, the study design is paired, and McNamar’s test for dependent
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proportions is recommended for these conditions (Zhou, Obuchowski, & McClish,
2011b).
3.2 Methodology
The null hypotheses for Aim 1, H0DM, states that for diabetes, CKD and heart disease, the
sensitivity and specificity of phenotype algorithms using ICD-10-CM and SNOMED will
be the same (Equation 1A). The alternative hypothesis, HADM, states that for each disease,
the sensitivity and specificity of phenotype algorithms using ICD-10-CM and SNOMED
exclusively will be different (Equation 1B).

Equation 1. Aim 1 hypotheses for comparison of ICD and SNOMED value sets
A.

Null hypothesis
𝐻0𝐷𝑀 : 𝜃𝑖𝑗 𝑃ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒(𝐼𝐶𝐷) = 𝜃𝑖𝑗𝑃ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒(𝑆𝑁𝑂𝑀𝐸𝐷)

B. Alternative hypothesis
𝐻𝐴𝐷𝑀 : 𝜃𝑖𝑗 𝑃ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒(𝐼𝐶𝐷) ≠ 𝜃𝑖𝑗𝑃ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒(𝑆𝑁𝑂𝑀𝐸𝐷)
Where 𝜃𝑖𝑗 is the true summary measure of the ith Disease Di, i=1-3
and jth Summary Measure Mj, j=1-2 for each phenotype algorithm.
Disease D= {diabetes, CKD, heart failure}
Summary Measure M= {Sensitivity, Specificity}

Study data included retrospective observational data collected in an Epic® EHR during
care delivery. The study included alive patients age 18 or older as of September 30, 2013
with at least one arrived or completed office visit encounter between October 1, 2013 and
September 30, 2016. The office visit criterion was to limit the study to patients who were

32

seen in the ambulatory setting, and are therefore candidates for chronic care management.
Study datasets for each disease state were extracted from the Epic® Clarity reporting
database, and contained demographics, diagnoses, laboratory results, and procedure
results to inform the reference standard phenotypes for diabetes, chronic kidney disease
and heart failure. The population represents the actual distribution of ethnic and racial
backgrounds, and gender served by UCSDH as no exclusion was made on the basis of
gender, race or ethnicity, pregnancy status, or sexual orientation. The study population
contained women of child-bearing potential, but the pregnancy status for individual
patients was not ascertained. Prisoners who received care at UCSDH were included, but
the investigators had no way of identifying which subjects were prisoners. Cancer
patients were also included, but cancer diagnoses codes were not relevant to the study,
and were not captured in the study data.
3.2.1 Phenotypes. Three types of phenotype rules for each disease were
implemented as SQL queries to extract patient cohorts from the research data: ICD
diagnosis only; SNOMED diagnosis only; and a reference standard based on research
phenotypes (Figure 10).
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Figure 10. Aim 1 Patient cohorts for ICD, SNOMED, reference standard phenotypes

VSAC value sets for VSAC Value Sets for Diabetes, Chronic Kidney Disease, Stage 5,
and Heart Failure were retrieved on May 22, 2016. See Appendix C Value Set Authority
Center Downloads for details. The Grouper Editor is the EHR activity for creating and
editing value sets within EpicCare Ambulatory 2015®. An embedded utility in the
Grouper editor was used to resolve the standard ICD and SNOMED terminology codes
into value sets of local diagnosis codes. Each local code has its own mapping to ICD-9CM, ICD-10-CM, and SNOMED CT. Hence, the internal terminology map was
externalized. Patient cohorts were identified when the local diagnosis ID matched a local
diagnosis in a patient’s problem list or office visit encounter history. The VSAC diabetes
value set contained 146 ICD-10-CM codes that mapped to 9,328 local codes. The utility
converted 36 SNOMED codes for diabetes to 7,118 local codes. Diabetes has the largest
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number of local codes of the diseases studies, but it not uncommon for value sets to
include thousands of local codes.
Table 5 provides examples of some of the complicating conditions encountered with the
code mappings. 1) Diabetes mellitus complicating pregnancy is a temporary condition
generally excluded from chronic care management. 2) Diabetes mellitus with HbA1C
goal between 7 and 8 blurs the distinction between controlled and uncontrolled by setting
an explicit goal. 3) Type 1 diabetes mellitus with peripheral angiopathy without gangrene
is mapped to two SNOMED CODES, 127014009 and 46635009. 4) Local code for Noninsulin dependent diabetes mellitus has no ICD-10-CM mapping. 5) Insulin dependent
type 2 diabetes mellitus, controlled is an example of why diabetic laboratory results can’t
be used to determine the type of diabetes. The term, “controlled” implies that the diabetic
patient would have normal readings on glucose and HgbA1c tests. 6,7,8) Depending on
the phenotype use case, granular descriptions of diabetes complications may or may not
be meaningful. If a clinician judges a term to be inappropriate for the intended use of the
data, it may be difficult to remove an individual term. For instance dropping ICD-10-CM
code E11.9 will remove 2) Diabetes mellitus with HbA1C goal between 7 and 8 and 5)
Insulin dependent type 2 diabetes mellitus, controlled.
Note that clinicians may not have visibility of all of these local code choices. Some are
marked as clinically inactive and some have never been applied to patient records.
However phenotyping algorithms routinely test whether any of the resolved local codes
appear on patient records.
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Table 5. Local diabetes code mapping examples
Local
Code

Term

ICD-9

ICD-10

SNOMED CT

1

Diabetes mellitus complicating
pregnancy

648.00
250.00

O24.919

609496007

2

Diabetes mellitus with HbA1C goal
between 7 and 8

250.00

E11.9

365845005

3

Type 1 diabetes mellitus with
peripheral angiopathy without
gangrene

250.71
443.81

E10.51

127014009

4

Non-insulin dependent diabetes
mellitus

250.00

5

Insulin dependent type 2 diabetes
mellitus, controlled

250.00
V58.67

E11.9
Z79.4

237599002

6

Type 2 diabetes mellitus with left
diabetic foot ulcer

250.80
707.15

E11.621
L97.529

1521000119100

7

Type 2 diabetes mellitus with
diabetic cataract

366.41

420756003

8

Type 2 DM w establish diabetic
nephropathy

250.40

420279001

Example

44054006

Public research phenotypes with established high sensitivity and specificity were adapted
for use as a reference standard for diabetes and chronic kidney disease. These algorithms
used discrete quantitative values in the medical record to define a disease state, such as
diagnoses, medications, laboratory values, and/or procedure findings. Although the
development of a reference standard was a necessary step in this study methodology,
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defining the best methods for reference standard development is outside the scope of this
research.
The Type 2 Diabetes Mellitus phenotype developed by the eMERGE network was used
as the reference standard with limited modifications (Pacheco, 2012).
This algorithm had 98.2%-100% Positive Predictive Value (PPV) when applied across
institutions (Northwestern University, Vanderbilt University, Marshfield Clinic) (Kho et
al., 2012). Based on the reported data from Kho’s table 3, I calculated sensitivity (.995)
and specificity (.986) of the algorithm over the 3 sites combined (N=350).
A number of challenges were discovered in adapting the research algorithm for use in the
population health context which are reported in Appendix D: Reference Standard for
Diabetes.

Table 6. eMERGE Diabetes Type 2 Case Inclusion Rules
eMerge
Type 1
Phenotype diabetes
Rule
DX

Type 2
diabetes
DX

Type 1
diabetes
Med

Type 2
diabetes
Med

Type 2 Med
prescribed before
Type 1 Med

Yes

Yes

Yes

1

No

Yes

2

No

Yes

3

No

Yes

4

No

5

No

Yes
Yes
Yes

Yes

Abnormal
diabetes
Labs

Yes

Yes

Note. Patient was included in diabetes reference standard cohort if any rule was met
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An eMERGE network phenotype was also selected for the CKD population. Nadkarni et
al. (2014) have reported a phenotype algorithm for CKD with a Positive Predictive Value
of 95.95 (CI 90.85-95.08) and a Negative Predictive Value of 93.25 (CI 90.85-95.08).
CKD patients were selected based on a diagnosis of CKD, kidney transplant, or other
kidney disease including renal failure and dialysis. Alternatively two laboratory measures
of GFR less than or equal to 60 over a period of 90 days or more confirmed a CKD
diagnosis. All CKD patients identified by diagnosis or lab, were then subject to a final
test of eGFR less than 15 to limit selection to CKD Stage 5.
The reference standard for heart failure identifies patients with ICD-9-CM or ICD-10CM code for heart failure in one active problem list diagnosis or two encounter diagnoses
or evidence of LVEF less than or equal to 40%.
3.2.2 Statistical Analysis. In order to fully understand how terminology mapping
affects cohorts, the coded diagnosis terms must be instantiated, i.e., programmatically
matched to EHR data. The unique study IDs of the ICD cohort were compared with
patient IDs in the reference standard, likewise the SNOMED cohort was compared to the
reference standard. The resulting True Positive, False Positive, True Negative and False
Negative values were recorded in 2x2 contingency tables as shown conceptually in
Figure 11. These values were used to derive the sensitivity and specificity of the ICD and
SNOMED diagnosis phenotypes for each disease.
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Figure 11. Conceptual diagram of the transformation of ICD, SNOMED and Reference
Standard Cohorts into 2x2 contingency tables.

The null hypothesis states that the sensitivity and specificity of the chronic disease
phenotype algorithms would be the same whether an ICD or SNOMED value set is used.
The McNamar’s test statistic, χ2 for sensitivity was calculated from the set of patients
with reference standard positive. Using Zhou et al. (2011b) notation, m111 is the number
of patients with both tests positive and m101 is the number with the first test negative and
the second test positive. The χ2 statistic for specificity is calculated from the set of
patients with reference standard negative. These values must be calculated directly from
the test data, and cannot be derived from a 2x2 contingency table. McNamar’s test for
dependent proportions was performed using SPSS version 24 (IBM, 2016) to evaluate the
statistical significance between the sensitivity and specificity of ICD and SNOMED
diagnosis phenotypes.

Equation 2. McNamar's χ2 statistics used to establish the significance of differences in
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sensitivity and specificity between ICD and SNOMED phenotype algorithms.
Sensitivity: for patients with
positive Reference Standard
(𝑚110 − 𝑚101 )2
χ2 =
𝑚110 + 𝑚101

Specificity: for patients with
negative Reference Standard
(𝑚010 − 𝑚001 )2
χ2 =
𝑚010 + 𝑚001

3.3 Findings
The study population included 201,917 patients age 18 or older with at least one office
visit during the study period. The demographics in Table 7 Age and sex of study
population represent the actual EHR population at that time. Percent of patients in each
age bracket was evenly distributed from 18-49 (18-29, 16.9%; 30-39, 16.3%; 40-49,
15.6%). The age distribution peaked between age 50-70 (50-59, 19.7%; 60-69, 17.0%),
the rapidly dropped off over age 80 (80-89, 4.1%; 90+, 0.7%). Gender was skewed
toward female (57.5 female vs 42.5% male). The missing information on sex was not
significant.
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Table 7. Age and sex of study population
Frequency

Percent

18-29
30-39
40-49

34,112
32,918
31,598

16.9
16.3
15.6

50-59

39,759

19.7

60-69
70-79

34,397
19,567

17.0
9.7

80-89

8,234

4.1

90+

1,332

0.7

Age

Sex

Frequency Percent

Female
Male
Missing

116,035
85,880
2

Total N=

201,917

57.5
42.5

Table 8 Race and ethnicity of study population was predominately white (61.0%). A
majority (76.5%) reported their ethnicity as “not Hispanic or Latino.” Legacy ethnicity
data of “African American” (306), “American Indian/Eskimo (18) “Asian/Pacific
Islander” (414), and “Caucasian” (3,014) were included in the count of “not Hispanic or
Latino”. The count of Unknown included Multi-Racial (971). There were 81 missing
values which were not significant.
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Table 8. Race and ethnicity of study population
Frequency

Race
American Indian or Alaska Native
Asian
Black or African American
Native Hawaiian or Other Pacific Islander
Missing
Other Race or Mixed Race
Unknown (Patient cannot or refuses to declare race)
White

Percent

905
19,398
8,558
828
1,428
36,305
11,348
123,147

.4
9.6
4.2
.4
.7
18.0
5.6
61.0

Frequency

Percent

Not Hispanic or Latino
Hispanic or Latino
Unknown
Missing

154,369
32,860
14,607
81

76.5
16.3
7.2
0.0

Total

201,917

Ethnicity

The details of the study population are for informational purposes only. Specific clinical
findings cannot be generalized to other populations, but the techniques for quantifying
phenotype performance are generalizable to the extent that they can be applied to any
population.
For diabetes, Table 9 shows the VSAC ICD and SNOMED value set phenotype
performance. ICD-10-CM outperformed SNOMED CT with higher true positives (9,345,
7471), lower false negative (1,934, 3808). ICD-10-CM was worse than SNOMED CT
with lower true negatives (185,285, 185,926), and higher false positives (5,349, 4,708).
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Overall, ICD-10-CM had greater sensitivity, and worse specificity. For diabetes,
McNamar’s χ2 (1,541.357) is greater than the critical value for sensitivity, and the null
hypothesis is rejected. McNamar’s χ2 (149.653) is also greater than the critical values,
and the null hypothesis is rejected for specificity. For the VSAC diabetes value sets, the
difference in sensitivity and specificity is significantly different for ICD-10 versus
SNOMED (p=0.001). ICD-10-CM sensitivity was better than SNOMED by 16.7%, and
the sensitivity was worse than SNOMED by 0.3%.

Table 9. Diabetes: VSAC ICD and SNOMED value set phenotype performance

Diabetes Value Sets

Reference Standard
Yes

No

Total

Yes

9,345

5,349

14,694

No

1,934

185,285

187,219

Yes

7,471

4,708

12,179

No

3,808

185,926

189,734

11,279

190,634

201,913

Sensitivity Specificity
0.829

0.972

0.662

0.975

ICD-10-CM

SNOMED-CT

Total
(McNamar’s test statistic χ2)
Critical value 10.827
df=1, level .001

1,541.357

149.653

Note that ICD-10-CM overall false positive and negative errors (7,283) were fewer than
SNOMED (8,516), and that the number of total errors were significantly higher than was
indicated by the change in the cohort census due to ICD-10-CM and SNOMED-CT value
sets performance (2,515).
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Table 10. CKD: VSAC ICD and SNOMED value set phenotype performance

CKD Value Sets

Reference Standard
Yes

No

Total Sensitivity Specificity

Yes

357

220

No

1,121

Yes

333

No

1,145

200,222 201,367

1,478

200,439 201,917

577

0.242

0.999

0.225

0.999

ICD-10-CM

SNOMED-CT

Total

200,219 201,340
217

550

(McNamar’s test statistic χ2)
Critical value 10.827
df=1, level .001

12.250

0

For CKD, McNamar’s χ2 (12.250) is greater than the critical value for sensitivity, and the
null hypothesis is rejected. McNamar’s χ2 (0) is less than the critical values, and the null
hypothesis is accepted for specificity. For CKD, the difference in sensitivity is
statistically significant, but specificity is the same for ICD-10 versus SNOMED.
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Table 11. Heart Failure: VSAC ICD and SNOMED value set phenotype performance

Heart Failure Value Sets

Reference Standard

Yes

Yes
3,675

No
0

Total Sensitivity Specificity
3,675
0.926
1.000

No

295

197,943

198,238

Yes

3,678

35

3,713

No

292

197,908

198,200

3,970

197,943

201,913

ICD-10-CM

SNOMED-CT

Total
(McNamar’s test statistic χ2)
Critical value 10.827
df=1, level .001

0.926

1.000

0

0

For heart failure, McNamar’s χ2 (0) is greater than the critical value for sensitivity, and
the null hypothesis is accepted. The sensitivity and specificity were the same.
3.4 Discussion and Recommendations
The inclusion rules selected to create specific chronic care cohorts are highly complex
and dynamic in clinically active electronic health records. The type of terminology
selected, such as ICD or SNOMED, may significantly impact cohort attribution.
The evidence shows that in the setting of diabetes, choice of diagnosis terminology does
make a statistically significant difference in the phenotype performance whereas this was
not shown to be true for heart failure. CKD showed improvement in sensitivity, but not
specificity.
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A more nuanced interpretation of the results can be made in the context of population
health use cases. If the objective is to find and effectively treat patients with uncontrolled
Type 2 diabetes, as in eCQM 122 Percent with HbA1c level > 9.0%, then errors of false
omission from the diabetes cohort will prevent the identification of uncontrolled patients.
Error rates can be read directly from the 2x2 contingency tables (Tables 9-11), and ICD
had 2575 fewer false omissions for diabetes than SNOMED. ICD also had fewer errors
overall than SNOMED for diabetes (7283, 8516), CKD (1341, 1362) and heart failure
(295, 327).
There are reasons to believe that this pattern may persist across other disease states.
The mapping error rate of ICD is likely to be lower than SNOMED because version ICD9 was originally developed in 1975 (Moriyama IM, Loy RM, & AHT, 2011), and has
decades of use and governance behind it. It’s universal, and ingrained in our medical
practice. SNOMED-CT’s low interrater reliability, would imply that phenotyping results
using SNOMED would likely be inconsistent, as the codes used to define a common
finding can be (Andrews et al., 2007).
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Chapter 4: Aim 2. Measure terminology maintenance impact on SNOMED cohorts
4.1 Introduction
Regulatory updates to address evolving terminology needs must be applied twice yearly
in a process that modifies diagnosis terms and maps between ICD and SNOMED. This
EHR terminology maintenance can produce secondary changes to cohorts coded in ICD
and retrieved by phenotype algorithms using SNOMED CT value sets. This Aim was
designed to capture quantitative evidence of the effect of the October 1, 2016 IMO
regulatory update on population health cohorts for diabetes, CKD and heart failure.
Like Aim 1, the Epic® 2015 Grouper editor utility was used to create the secondary value
set of the local diagnosis codes mapped to VSAC value sets thereby externalizing the
mapping of local codes to standard diagnosis terminologies. The resolved versions of
VSAC value sets were captured before (May 22, 2016) and after the terminology
maintenance (November 6, 2016).
4.2 Methodology
The null hypotheses for Aim 2, H0DM, states that for diabetes, CKD and heart disease, the
sensitivity and specificity of phenotype algorithms using SNOMED exclusively will be
the same before and after terminology maintenance (Equation 2A). The alternative
hypothesis, HADM, states that for each disease, the sensitivity and specificity of phenotype
algorithms using SNOMED exclusively will be different before and after terminology
maintenance (Equation 2B).
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Equation 3. Aim 2 Hypotheses for comparison of SNOMED value sets before and after
terminology maintenance
A) Null hypothesis 𝐻0𝐷𝑀 : 𝜃𝑖𝑗𝑘 𝑃ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒{𝑆𝑁𝑂𝑀𝐸𝐷, 𝑇1} =
𝜃𝑖𝑗𝑘𝑃ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒{𝑆𝑁𝑂𝑀𝐸𝐷, 𝑇2}
B) Alt hypothesis 𝐻𝐴𝐷𝑀 : 𝜃𝑖𝑗𝑘 𝑃ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒{𝑆𝑁𝑂𝑀𝐸𝐷, 𝑇1} ≠
𝜃𝑖𝑗𝑘𝑃ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒{𝑆𝑁𝑂𝑀𝐸𝐷, 𝑇2}
Where 𝜃𝑖𝑗𝑘 is the true summary measure of the ith Disease Di, i={1,2,…n}
and jth Summary Measure Mj, j={1,2} at Time Tk j={Before, After} for each phenotype algorithm
Disease D= { DM, CKD, HF }
Summary Measure M= {Sensitivity, Specificity}

The shaded cohort in Figure 12 represents the VSAC SNOMED cohort at Time 2. The
same SNOMED and reference standard cohorts described in Aim 1 were also used in
Aim 2.

Figure 12. Aim 2 cohorts (before terminology maintenance, after maintenance, and
reference standard)
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The resulting True Positive, False Positive, True Negative and False Negative values
were recorded in 2x2 contingency tables as shown conceptually in Figure 13. These
values were used to derive the sensitivity and specificity of the SNOMED diagnosis
phenotypes for each disease before and after terminology maintenance.

Figure 13. Comparison of VSAC SNOMED cohorts to a reference standard

4.3 Findings
Table 12. Diabetes: VSAC SNOMED phenotype performance before and after
terminology maintenance

Diabetes Value Sets

Reference Standard

SNOMED-CT

Yes

Yes
7,471

Before

No

3,808

185,926

189,734

SNOMED-CT

Yes

7,708

4,844

12,552

3,571

185,790

189,361

11,279

190,634

201,913

After
Total

No

No
4,708

(McNamar’s test statistic χ2)
Critical value 10.827 df=1, level.001

Total Sensitivity Specificity
12,179
0.662
0.975

0.683

174.596
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0.975

99.049

McNamar’s χ2 test statistics for diabetes sensitivity (174.596) and specificity (99.049)
exceed the critical value of 10.827, and the null hypothesis is rejected for diabetes.
Differences in sensitivity and specificity between ICD and SNOMED algorithms are
statistically significant (p = 0.001). Although the value set had not changed, the local
EMR terminology maintenance on October 1, 2016 resulted in increased sensitivity from
0.662 to 0.683 (p <=0.001). The census change in the cohort (237) does not reflect the
true magnitude of the change (319) with 278 patients added and 41 patients excluded.

Table 13. CKD: VSAC SNOMED phenotype performance before and after terminology
maintenance

CKD Value Sets

Reference Standard

SNOMED-CT

Yes

Yes
333

Before

No

1,145

200,222

201,367

SNOMED-CT

Yes

334

217

551

1,144

200,222

201,366

1,478

200,439

201,917

After

No

Total

No
217

Total
550

(McNamar’s test statistic χ2)
Critical value 10.827
df=1, level .001

Sensitivity Specificity
0.225
0.999

0.226

0.999

0

0

McNamar’s statistic (0) was less than the critical value (10.827) for both sensitivity and
specificity. The null hypothesis is accepted. There was no change for CKD and heart
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failure as a result of the terminology maintenance It is important to note that findings
may vary by disease state due to the unique features of the lexicon of disease diagnoses.

Table 14. Heart failure: VSAC SNOMED phenotype performance before and after
terminology maintenance

Heart Failure Value Sets

Reference Standard

SNOMED-CT

Yes

Yes
3,678

No
35

Total
3,713

Before

No

292

197,908

198,200

SNOMED-CT

Yes

3,678

35

3,713

292

197,908

198,200

3,970

197,943

201,913

After

No

Total
(McNamar’s test statistic χ2)
Critical value 10.827
df=1, level .001

Sensitivity Specificity
0.926
1.000

0.926

1.000

0

0

McNamar’s statistic (0) was less than the critical value (10.827) for both sensitivity and
specificity. The null hypothesis is accepted. There was no change for CKD and heart
failure as a result of the terminology maintenance It is important to note that findings
may vary by disease state due to the unique features of the lexicon of disease diagnoses.
4.4 Discussion and Recommendations
The performance of SNOMED value sets can change over time even if the value set itself
remains unchanged. Changes in a cohort census may not reflect the true magnitude of the
change because patients added and excluded offset each other. Unexpected changes in
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cohort membership require clinical validation to determine if the change is good, bad, or
irrelevant. This study demonstrates that periodic EHR maintenance to apply terminology
updates may cause discontinuities in the size of chronic disease cohorts. This is not the
only cause for unexpected shifts in population health registries census. Technical
problems related to the nightly load of registry data marts, EHR application upgrades,
and customization activity have been known to affect registry census in dramatic ways.
The first step in addressing these problems is to detect them. The development of EHR
registry systems that automatically monitor their own performance would remove burden
from the IT staff, making it more likely that anomalies are detected.
Recommendation: Best practice for maintenance of EHR registries requires longitudinal
monitoring of daily census.
Diagnosis terminology maintenance may cause unpredictable, but potentially large
changes in the census of SNOMED-CT cohorts. The development of novel phenotype in
SNOMED terminology is easier and less time-consuming because many ICD codes can
be represented by a single SNOMED concept. (Lieberman et al., 2003) However, this
same characteristic increases the probability of large changes in SNOMED cohorts due to
terminology maintenance.
Recommendation: ICD is the preferred terminology for population health cohort
algorithms.
Testing can mitigate the impact of terminology maintenance on population health
cohorts. Phenotype algorithms using SNOMED value sets should be retested with each
terminology update. If significant performance degradation is found, the inclusion rules
can be adjusted as necessary, and retested under the new mapping conditions.
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Recommendation: Best practice for SNOMED value sets requires retesting of algorithm
performance when terminology updates are applied. Adjustments to the code sets can
then be applied as needed.
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Chapter 5: Aim 3. Recommend methods for improving population health
interventions
5.1 Introduction
The development of phenotypes for population health cohorts is embedded within the
larger context of deploying technology-aided clinical workflows. A body of work has
informed the importance of the socio-technical dimension of EHR implementations, and
Aim 3 applies the socio-technical model developed by Sittig and Singh (2010) for
studying health information technology in complex adaptive healthcare systems.
5.2 Methodology
The eight dimensions of the socio-technical model all relate in some way to the
interaction of patients, the healthcare workers who serve them, and the computer systems
that initiate care alerts and track the data collected during the delivery of healthcare. The
social perspective, or the human side of this interaction is concerned primarily with the
dimensions of People, Workflow and Communication, Internal Organizational Policies,
Procedures and Culture and External Rules, Regulations and Pressures. The technical
perspective addresses the Hardware and Software Computing Infrastructure, Clinical
Content, Human Computer Interface, and System Measurement and Monitoring.
Observations across these domains were informed by literature research and experiential
knowledge gained over a five year period during which the author was responsible for
design, development, implementation and support of a population health registry
infrastructure at an academic medical center.
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5.3 Findings
The findings are organized by social and technical domains, and informed the practical
methodology for improving population health interventions.
5.3.1 Social Domains. People refers to anyone who engages in the population
health program in some way. Workflow and Communication involves the recognition and
treatment of chronic disease in population health programs. Internal Organizational
Policies, Procedures and Culture and External Rules set standards of practice for
managing clinical data. All of the domains are impacted by Regulations and Pressures
driving the adoption of population health care delivery model..
The dimension of People as defined in this study includes the humans directly involved
in population health programs. Three subcategories were explored: 1) patients; 2)
clinicians 3) information technology (IT) workers.
Patients contribute clinical data points used to form disease cohorts, yet each group is
comprised of individual patients with unique histories, disease manifestations, and
choices. Study participants were weighted toward mature female adults. Two thirds of
patients were age 40 or over and 57.5% were female. The prevalence of chronic disease
and comorbidity increase with age. Therefore, population health programs can apply
lessons learned about communication and treatment preferences for this age group.
Recent findings imply that assumptions about the use of communication technology by
older adults may be breaking down. Ruppel, Blight, Cherney, and Fylling (2016) found
evidence that the text-based format of e-mail might help older adults compensate for
hearing impairment of communicative difficulties.
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The challenge of chronic disease is to diagnose and treat patients before disease
progression permanently damages body systems. Perhaps the greatest opportunities for
promoting wellness healthy lifestyles will occur in the 18-40 year old population. This
age group is more likely to be comfortable with the online platforms of patient portal.
Patient-centered display of clinical markers of disease as well as plans for care help
engage the patient in the management of a chronic condition. The portals provide a
secure messaging interface to report errors in the data or plans, and patients will likely
have a growing role in monitoring and improving their own health care data. To address
individual needs, population health intervention triggers must be designed with a
personalization feature to turn them off when recommendations have been made in error
or an intervention is otherwise contraindicated or refused. Historically, patient advisory
boards have had little or no role to date in the design of the patient portal interface for the
chronic disease management interfaces, but certainly could be leveraged to provide
feedback that would inform improvements in usability and effectiveness.
Clinicians bear the responsibility for applying the clinical diagnoses. Historically, the
diagnosis would have been written in free text in a physician note, but this type of
information has been a challenge for computers to capture and process. A widespread
approach to solving this problem is to have the doctor perform a text search on a
diagnosis term, and choose the best match from a drop-down list. The EHR used in this
study maps thousands of diagnosis terms between four terminologies, the local diagnosis
codes and three standard diagnosis terminologies, in a complex web of many to many
relationships. The goal and promise of the terminology vendor is to make it as easy as
possible for a provider to find a clinical term (diagnosis) on the list of available terms. A
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surplus of synonymous terms may actually impede the selection of the “correct” code,
and the mapping adds complexity and fuzziness to the retrieval of these codes. Operating
in a time-constrained care delivery system, the clinical collects historical, symptom,
exam, laboratory, procedural and genetic information over time to accurately select the
right diagnosis. In comparison, the phenotype algorithms being used to group patients for
care interventions contain relatively few data points. The patient with chronic disease is
also on a dynamic path of disease progression in which age, lifestyle, comorbidities and
medication can influence quantitative laboratory measures of a disease state.
Resnik, Niv, Nossal, Kapit, and Toren (2008) made an early study of trade-offs between
structured input and unrestricted free text clinical notes, and in fact both formats exist
side by side in current EHR. As natural language processing (NLP) systems develop,
computer assisted coding in clinical care delivery may develop with similar features to
systems currently supporting administrative coding used for billing. However a recent
systematic review of NLP systems for capturing unstructured clinical information reports
continuing challenges with extraction of temporal information and normalization of
concepts to standard terminologies (Kreimeyer et al., 2017).
It should be noted that clinicians engaged in population health programs are often
supported by nurses, care managers or health coaches in a team-based care model. Due to
the wide variety of licensed and unlicensed healthcare workers and team models, this
group of population health practitioners was deemed to be out of scope for this general
review.
Information technology (IT) workers recruited into the emerging practice of population
health often lack the training and knowledge to navigate complex terminology decision
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and implement statistical measurement of phenotypes. There is currently no professional
or academic program specific to the development and application of population health
interventions, and the content is complex and rapidly changing. The knowledge and
practice of population health medicine should be encapsulated in training/certification
programs for practitioners. The population health IT analyst performs best in a
multidisciplinary team that also includes clinical subject matter experts, clinical
operations leaders, data and financial analysts that report to executive leadership.
A challenge in the Workflow and Communication dimension relates to the recognition
and communication of diagnoses. Undiagnosed illness prevents patients from benefiting
from treatment, and raises the risk of complications. CDC estimates that there are 30.3
million people with diabetes in the U.S., 7.2 million of those are undiagnosed (Centers
for Disease Control and Prevention, 2017). Accurate clinical phenotypes can identify
patients with missed diagnosis of chronic disease and inform prognostic prediction
models that predict the risk of developing a disease, a comorbid condition, or mortality at
a specific point in the future (Hsieh, 2017). New clinical workflows will be necessary to
identify, verify, and inform patients that meet a disease phenotype without a
corresponding diagnosis. When computer algorithms detect what appears to be a “missed
diagnosis” clinical staff need a plan for verifying the diagnosis and sharing this
information with the patient. This type of outreach can begin to address the issue of the
undiagnosed chronically ill.
The domain of Organizational policies and procedures includes the important topic of
governance. There continues to be sizable local variation in the collection and storage of
clinical data. Data governance structures within an organization can lead decision making
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related to what data to collect, how to code it, and where to store it. Without health
system governance, choices regarding the collection and storage of data may proceed in
an ad hoc fashion, complicating the retrieval and analysis of data for population health
and quality reporting.
The domain of External rules, regulations and pressures encompasses the forces driving
the adoption of population health care delivery model. These include technological
advances, emphasis on evidence-based care, shift to outpatient care, change to valuebased reimbursement and shared risk structures with payers (FitzGerald, 2017).
CMS national quality programs create de facto standards for quality measurement, and
incentivize the use of population health interventions. Improvement in the clinical
validity of chronic disease value sets by CMS would be an important step toward
reducing the national burden of value set development and maintenance. For instance a
quality measure about statin therapy for cardiovascular disease should not have a
congenital anomaly (not appropriate for statin treatment) included in the diagnosis value
sets.
5.3.2 Technical Domain. The technical perspective addresses the Hardware and
Software Computing Infrastructure, Clinical Content, Human Computer Interface, and
System Measurement and Monitoring.
The Hardware and software domain is dominated by EHR systems. The existence of
registry functionality within the EHR system is relatively new. The term Sustainable,
Timely, Operational Registries in the EHR (STORE) has been suggested to differentiate
this type of registry from traditional registries that are external to the EHR and unable to
trigger delivery of clinical care or patient communication (Berkovich, 2016). EHR
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registries hold the promise to drive down the cost of care through efficiencies of scale,
and are becoming an essential tool in the ambulatory setting for delivering high quality
care as defined by evidence-based practice and national quality measurement programs.
However, the application tools to develop, validate and manage the clinical interventions
in a scientific manner are still evolving. New temporal measures like persistence of
abnormal lab results over a 90 day period should come standard in the registry metric
calculation toolbox as well as tools to better identify, validate, and quantify and visualize
phenotype performance.
The Clinical content domain is dependent upon standards. The sharing of diagnosis
algorithms and by extension, phenotypes requires adherence to content standards such as
LOINC, RXNORM, REAL (Race, Ethnicity, and Language), etc. As was discovered in
the implementation of the eMERGE diabetes reference standard, the ability to use a
standard does not equate with effective use. The Meaningful Use quality program did
effectively require the identification of patient phenotypes by ICD codes, and MACRA
MIPS will require reporting of SNOMED codes in 2018. CMS could speed the adoption
of standard lab results and medications terminologies by requiring quality measures to be
reported using LOINC and RXNORM codes, respectively.
Computer assisted coding (CAC) systems must have a well-defined basis for evaluating
their own correctness. To answer the question, “How does the system know it’s right?”
Resnik offers a generalized formula for sensitivity to quantify the performance of CAC
(Jiang, Nossal, & Resnik, 2006).
Equation 4. Resnik’s formula: How does the system know it’s right?
Pr( choice C is correct | evidence).
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To achieve high levels of sensitivity and specificity, previous studies have concluded that
ICD-9 codes are not sufficient for identifying patient cohorts (Shivade et al., 2014). In
addition to laboratory reports, procedure results, medications, and demographics used in
the eMERGE reference standards, phenotypes algorithms may need to include novel data
items such as geo codes, social determinants, patient reported data, calculated data such
as average blood pressure, and risk scores. Free text evidence in the EHR not routinely
recognized by EHR registry inclusion rules could provide additional evidence on which
to base phenotyping choices. External data such as public death records may be used in
the future to prevent outreach to deceased patients.
The future development of the inclusion algorithms must account for the signal strength
of each element. For instance, an encounter diagnosis that appears 24 times in a patient
record is more reliable than another that may appear once. Diagnosis codes are also found
in Medical History, and billing codes, and free text notes.
The dimension of the Human-computer interface has been well studied when applied to
the use of an operational EHR application, but less so in the study of the tools used to
develop and maintain population health applications. The task of creating and assessing
value sets as practiced today is highly complex, and introduces numerous opportunities
for human error. The number of codes in diagnosis value sets may be trivial for a
computer, but can seem large in human terms. For example the VSAC ICD-10 value set
for diabetes had 146 codes and SNOMED had 36 codes. Due to the hierarchical nature
concepts, SNOMED CT value sets typically have fewer codes than ICD. Humans
manually entering value sets may have a natural bias toward SNOMED CT because it
appears to be quicker and easier. This bias does not take into account the retrieval
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properties of SNOMED that appear to have lower performance scores and are known to
cause unpredictable shifts in some patient cohorts as a result of terminology maintenance.
Best practice would dictate that value set editors should display both the computer
readable code and the human readable term side by side, but this is not currently a
requirement of certified EHR systems. A direct method for importing national value sets
into the EHR would also ease the burden of value set creation. Although EHR systems
allow a great deal of flexibility in designing an algorithm, the tools to assess the
performance of one value set as compared to another or against a reference standard are
limited. The addition of statistical analytics and visualizations to phenotyping toolkits
would increase the availability of comparative data upon which to make scientifically
based phenotype decisions.
The domain of System measurement and monitoring is garnering greater attention due in
part to patient safety studies on clinical decision support systems (Wright et al., 2017).
The choices in the Value Set Authority Center for common diseases exceeds human
capacity to select and compare. Searchable ratings indicating a range of value set
performance like sensitivity, specificity, false discovery rate, false omission rate in
multiple settings should be reported for value sets maintained within its library.
VSAC contains value sets, but the development of accurate phenotypes will require
multiple terminologies within a single phenotype. These algorithms should be evaluated
against standard EHR implementations and published with measures of performance.
Similar to national quality metric definitions, national disease phenotypes should be
published that include multiple clinical domains like diagnoses, labs, procedures, etc.
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Computer Assisted Coding (CAC) systems scans medical records and supports human
coders by suggesting ICD billing codes supported by clinical documentation. This model
could be used for augmented diagnosis tools that would suggest codes based on clinical
evidence, risk factors and local prevalence. Resnik suggests quality measures for CAC
systems should address completeness, correctness, and non-redundancy. Resnik discusses
a similar process as applied to Computer Assisted Coding.
When evaluating a system intended to match human expert performance, issues to
address include defining test data, selecting performance measures, determining
what responses the system should produce, and deciding whether particular levels
of performance are “good enough, ”(Jiang et al., 2006)
Hripcsak and Heitjan (2002) addressed the problem of assessing the performance of a
decision support system when there is no definitive way to know the true state of the
patient.. Their study also compiled results in a two-by-two contingency table, and then
compared the statistics of observed agreement, specific agreement, and Kappa. Kappa is
defined in terms of the observed agreement and agreement expected by chance (Hripcsak
& Heitjan, 2002). The specific recommendation for dichotomous data concludes that
showing the two-by-two contingency table with its marginal totals is probably as
informative as any measure.
Studies comparing overlapping sets may provide formulas that may useful for measuring
how much similarity and difference between two phenotype rules run against the same
population. The use of Venn Diagrams in visualization may be a cognitive aid to help
analysts understand and communicate the difference between the test rule and the
reference standard or two versions of the same rule.
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5.4 Discussion and Recommendations
The population health care delivery model exists within a socio-technical system, and
will need both workflow and technology changes to succeed. The socio-technical model
provides a framework from which to study health IT interventions within a complex
adaptive health care system (Sittig & Singh, 2010). A Socio-Technical Approach to
Population Health Programs is outlined in Table 8. This practical method was
synthesized from findings in this study, direct experience and published literature
(Shivade et al., 2014).

Table 15. Socio-Technical Approach to Population Health Programs
Task

Description

Begin with defined goals

National quality programs are often the starting point
for Population Health. Consider available resources to
carry out planned interventions

Form the team

Health IT analysts need clinical oversight, operational
and executive support

Build a reference standard

Start with a research phenotype or diagnostic tests

Design and test the inclusion
rule

Rapid iteration and refinement of the inclusion rule
using quantitative phenotype scores will lead to the
best inclusion rule

Report phenotype
performance including error
rates

Report 2x2 contingency table, Sensitivity, Specificity,
Error Rates and F score

Implement the population
health plan

Find the most efficient and effective outreach methods

Measure success

Collect baseline data, and track progress toward goal

64

5.4.1 Begin with defined goals. Goals, resource constraints, error limits, and
measures of success will all contribute to design decisions when developing a new
population health intervention. Many organizations set a goal of “building a registry” or
“doing population health” without being specific about the parameters of the project.
Regulatory quality measures have pre-defined processes and performance targets. There
may also be a strong financial motive to deliver value-based care and earn incentives
payments based on quality performance. Population health systems provide a framework
to support and measure health interventions, but ultimately the project should
demonstrate meaningful results. Health outcomes that matter to patients, providers and
payers include reduction in development of new disease, health complications,
emergency or hospital visits, and mortality. Health systems may also be financially
incentivized or penalized for performance on quality measures. The work queues and
intervention alerts must be scaled to the staff available to process the work, therefore
resource constraints must be considered in algorithm design. For example, it’s
counterproductive to refer 1,000 patients to a health coaching resource that can only serve
500. In the setting of capitated payments or value-based care, the size of the patient
cohort will inform the costs and resources required to carry out the intervention, whereas
medical complexity, multimorbidity and social determinants will impact the intervention
design and likelihood of success. The inclusion and exclusion error rates are associated
with their own risks and costs, and should be considered when making terminology
selections. Resnik discusses a similar process as applied to Computer Assisted Coding.
When evaluating a system intended to match human expert performance, issues to
address include defining test data, selecting performance measures, determining
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what responses the system should produce, and deciding whether particular levels
of performance are “good enough.” (Jiang et al., 2006)
5.4.2 Form the team. Population health is a type of surveillance system used to
ensure that patients receive the appropriate standards of care. The requirements for
population-level response for patient safety incidents as described by Hibbert et al.
(2016) can easily be adapted to population health. A multidisciplinary team that includes
clinical subject matter experts, clinical operations leaders, IT and financial analysts, and
data scientists will provide the right skillset for a successful population health program.
Executive sponsorship and support is generally required within a large organization to
direct resources and budget to population health activities. Smaller practices may choose
to procure third-party population health services or hire consultants to help them with the
task. Patient advisory boards increasingly pivotal in guiding the timing and approach of
messaging and patient portal interfaces for chronic disease management.
5.4.3 Build a reference standard. Statistics that compare phenotoype performance to
a reference standards are much more informative than those that just compare differences
between cohorts. In the latter, positive and negative changes to patient cohorts can offset
one another to mask the true number of differences. Validated clinical phenotypes may be
found in the medical literature and at PheKB.org a phenotype knowledge based
developed the Electronic Medical Records and Genomics (eMERGE) network. Perhaps
in the future, open source data sets will support reference standard development.
5.4.4 Design and test the inclusion rule. Organizations committed to the
development of a population health program to drive a quality measure to its goal may be
tempted to use the quality measure definitions of numerator and denominator as specific
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design criteria. However, as demonstrated, the value sets supplied by a quality program
may not be optimized for delivery of clinical care. Although national value sets may be a
good starting point, clinicians may recommend refinements to remove patients with
contraindications or temporary conditions. After diagnosis criteria has been optimized,
additional clinical indicators of disease should be iteratively added and tested to drive the
performance of the inclusion rule toward the level of the reference standard itself. One
may wonder why the reference standard is not implemented directly as the inclusion rule.
Some registry platforms are limited to the logical constructs or data types that can be
implemented as inclusion rules. For example, the persistence measure for elapsed days
between abnormal lab results may not be implemented in the EHR such that it can be
utilized as a registry inclusion rule. Work-arounds may exist, but may not be practical
with the constraints of budget, skills, and implementation schedules. If the phenotype
query captures and reports the data underlying the decision variables the validation time
will be significantly reduced.
There is a natural trade-off between sensitivity and specificity which are both
measures of intrinsic diagnostic accuracy unaffected by the prevalence of the condition
(Zhou, Obuchowski, & McClish, 2011a). Quantitative measurement of the algorithms
helps with design decisions. The F score is a convenient single statistic to compare any
number of similar algorithms while balancing sensitivity and specificity.
5.4.5 Report phenotype performance including error rates.
From the perspective of cohort development, simplification within and clear separation
between cohorts are of high importance. Although phenotyping techniques have
improved over the past few years, there is still room for improvement (Shivade et al.,
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2014). There is now also a need for EMR phenotype algorithms that can perform well
across populations where the patient characteristics may vary (Liao et al., 2015). Too
often, the same task is being repeated at multiple institutions (Shivade et al., 2014). Yet,
“incomplete reporting has been identified as a major source of avoidable waste in
biomedical research,” (Bossuyt et al., 2015). The use Standards for Reporting of
Diagnostic Accuracy Studies (STARD), or a derivative of those standards for use in
population health studies will ensure that essential items are reported in phenotyping
studies. Statistics of particular importance for population health are the 2 x 2 contingency
table from which one can calculate the False Omission Rate, False Discovery Rate,
Sensitivity, Specificity and the F Score.
5.4.6 Implement the Population health plan. Lessons learned from the
implementation of Health IT systems can inform the practice of population health. The
ten guidelines for HIT Design for Chronic Disease Care provide a useful list to consider.
(Unertl, Weinger, Johnson, & Lorenzi, 2009)
5.4.7 Measure your success and share lessons learned.
Healthcare reform in the U.S. focused on providing value for the patient in terms of
health outcomes achieved per dollar spent. Measurement and dissemination of health
outcomes will become universally mandated. (Porter 2009) Population health programs
should be able to demonstrate that they are providing anticipated outcomes. Collect
baseline data, and track progress toward the defined goals.
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Chapter 6: Synthesis and Summarization

This research confirms that terminology mapping considerations are important in
managing population health cohorts. This is a formidable challenge because mapping
local data to standard terminologies and between terminologies impacts every EHR
system. Additionally, medical terminology systems are complex, and are continuously
evolving. Maps between large terminologies and ontologies can introduce phenotype
errors, and work is needed to better understand how value sets and mappings shape
population health cohorts and affect quality measurement. Although research continues
on automating the mapping process, there is still a degree of judgement and imperfection
introduced as humans develop terminology maps, apply codes to the patient health
record, and retrieve chronic care cohorts.
The terminology vendor, by providing maps from local terms to national standards
delivers middleware functions as its own coded terminology. Certified EHRs actually
support and cross-map four terminologies (local/vendor supplied, ICD-9, ICD-10, and
SNOMED). When a clinician searches an EHR for a diagnosis term that fits a patient’s
presenting condition, a local code is displayed that maps the clinical term supplied by the
vendor to an ICD-10 code. When Brown declared in 2005 that ICD-9 was an obsolete
coding system, she was reinforcing the belief that ICD, designed as classification system,
could not provide the necessary granularity to capture the clinical language and nuance
used by physicians. ICD-9, has not been fully retired, but continues to be applied to
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patient records through the terminology mapping process, mainly for research purposes.
ICD-11 is under development, and will be finalized in 2018. (World Health Organization)
Population health systems must be continually reviewed and maintained to stay in sync
with the changes.
6.1 Conclusion and Recommendations
Population Health is growing in importance as a care delivery model as national valuebased care programs seek to contain cost and improve outcomes. In the setting of
capitated payments and the value-based care paradigm, patient cohort attribution can
impact the costs, resources, and interventions. Phenotype inclusion errors raise the risk of
patients receiving inappropriate care and exclusion errors raise the risk of missing
standard care interventions, and the failure to implement population health programs with
little attention to socio-technical dimensions can result in sub-optimal results. CMS is in a
unique position to develop and require new scientific methods to assign and evaluate
chronic disease cohorts.
In some cases, tools and value sets developed for quality reporting programs are being
applied in a clinical context they were not designed to support. As required levels of
compliance on some measures approach 100% and sizable incentives and penalties
impact individual doctors and health systems alike, there is a new imperative to
quantitatively and scientifically evaluate population health cohorts with high levels of
precision.
This limited study suggests that ICD should be the preferred terminology for population
health cohorts in the absence of data to the contrary. Research has shown diagnosis
phenotypes using ICD alone are not sufficient, and diverse data sources are being utilized
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to improved phenotype results (Shivade et al., 2014). The set of national value sets for
identifying chronic disease cohorts will need to develop into a library of national
phenotypes that include ICD values sets, and also look beyond readily available diagnosis
codes to include other evidence of disease such as labs, procedures, medications,
questionnaires, and medical devices. These phenotypes will include multiple
terminologies standards (LOINC, RXNORM, etc), and health systems should be required
to produce quality reports using those standards. The use of SNOMED terminology in the
MIPS quality program promises to generate valuable data in 2018 and beyond.
Lack of portability and restrictions on data sharing have left the development of clinical
cohorts largely isolated within each health system, and it’s a herculean task. Within each
local instance of an EHR, efficient and accurate data capture and governance is
paramount, for this data both drives the delivery of care and collects raw material for Big
Data systems. While Big Data may be part of the solution, federated research networks
have, by design, added another layer of mapping that masks the operating characteristics
of the local EHR. Phenotyping studies in a Big Data network may inform the overall
design of phenotype logic, but there is currently no established method for distributing
phenotypes across EHR systems. Decentralized local development and common sharing
of methods and results may be the only way forward in the near future. Common
standards for reporting methods and de-identified aggregated results would be required
for this approach to be effective. STARD (Standards for Reporting Diagnostic Accuracy),
which is currently used for diagnostic studies provides a relevant model.
Although the focus on population health programs is often centered on the technology,
the social aspects of system development implementation and measurement equally
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apply. Local health systems need multidisciplinary teams who are trained to improve
phenotype testing and refine diagnostic algorithms using quantitative scientific methods.
Data governance bodies within the health system are needed to inform decisions on what
data to collect, how to code it, and where to store it. As national, state, professional, and
local quality programs continue to mandate the reporting of quality measurements, it is a
shared responsibility of the medical community to ensure that the data, itself, is high
quality.
Terminology mappings within an EHR can be very difficult to discern by clinicians and
application analysts. Population health platforms, whether they exist within an EHR or a
third party provider should deliver tools for monitoring and reporting fluctuations in
registry census. Without this feature, unexpected changes to patient cohorts may be go
undetected, but should be evaluated by a clinician. A summary of these recommendations
may be found in Appendix E. Recommendations for Quality and Population Health
Programs.
6.2 Limitations
This study was limited to one organization, but the inclusion of the entire population of
nearly 200,000 patients enabled the calculation of the phenotype performance with high
precision (p=0.001). Nevertheless, it is the methodology and practice of population health
phenotyping that this work seeks to inform. Only one EHR platform was studied, but the
platform is one of the top six, and used by 55% of the customer base selected to
implement population health systems within their local EHR. According to HIMSS, “less
than a third U.S. hospitals surveyed are using a solution from their vendor for population
health,” (FitzGerald, 2017). The single terminology product included in the study is
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incorporated into several of the leading EHR systems, and is nearly universal within the
industry. Alternative terminology resources are U.S. National Library of Medicine
(NLM) for SNOMED CT, and the Department of Health and Human Services for ICD10. Apelon® also offers an open source terminology product that supports HL7’s FHIR®
Terminology Service. The value sets were drawn from a single source, the Value Set
Authority Center, the repository for official versions of diagnosis value sets for
regulatory quality programs such as Meaningful Use and Clinical Quality Measure. It is
the only source of publicly available SNOMED value sets.
Only three disease states were considered. Nevertheless, this study clearly demonstrates
that each disease condition has its own unique challenges and characteristics. Diabetes is
the sentinel disease in the phenotypes studied. Numerous studies have linked diabetes to
CKD and heart failure, including United Kingdom Prospective Diabetes Study. UKPDS
developed a model to estimate the lifetime health outcomes of patients with Type 2
Diabetes based on their likelihood of developing renal failure, heart failure, ischemic
heart disease, myocardial infarction, stroke, amputation, or blindness (Clarke, 2013). The
prevention and treatment of CKD is a key priority of the Healthy People 2020 initiative
coordinated by the U.S. Department of Health and Human Services. To that end Healthy
People 2020 goals include increased testing of microalbumin levels in persons diagnosed
with diabetes, and increased testing of serum creatinine, lipid, and microalbumin in
persons with CKD (United States Renal Data System, 2017). CKD has been targeted as a
model for improving chronic disease through electronic health records because the
disease is common, and objective laboratory data is used for diagnosis and monitoring of
disease progression (Drawz et al., 2015) (Navaneethan et al., 2013). The heart failure
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algorithm was only designed to detect systolic failure, which lowers the LVEF. Diastolic
failure was not included in the phenotype.
Evidence in the reference standard was based on a limited dataset of discrete data. For
example, diagnosis information was evaluated in problem lists and ambulatory encounter
diagnoses. More evidence of disease state could be found in free text notes, scanned PDF
files, external data records, and other discrete locations for diagnosis codes such as
inpatient diagnoses or billing records. Information on patient deaths and change of health
care provider impact cohort size as well, but this information is not routinely entered into
the clinical record because these patients no longer have an active patient relationship
within the health system. More data, however, does not necessarily mean better data.
Each new data source for each disease state needs to be evaluated at the local level in
isolation to avoid adding data that will introduce more uncertainty and noise than
valuable insight. Associations between data could also be used as to improve phenotype
performance. For example, in CAC systems, the computer can use a crosswalk table to
determine which ICD diagnosis codes and CPT procedure codes can be used together
(Jiang et al., 2006). A recent review of published phenotype studies show that
probabilistic methods and NLP techniques have been gaining popularity as compared to
rule-based systems (Shivade et al., 2014).

6.3 Future Work
As value-based care becomes more prominent both as a care paradigm and a
reimbursement philosophy, the number of organizations engaged in population health
interventions is on a steep growth curve. A HIMSS Analytics survey of 104 IT leaders in
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U.S. hospitals found that the number of organizations with population health programs
has grown from 67% to 76 % from 2015-2016 (FitzGerald, 2017). Key challenges
reported focused on technology, data and resources. To achieve improvements in
analytics, performance measurement, and care coordination, population health tools must
continue to develop in sophistication, while also becoming easier to use. There is a
knowledge gap about what needs to be done, and proper implementation and roll out of
programs (FitzGerald, 2017).
As health care providers strive deliver quality care and meet measurement targets,
dynamic registries in the EHR that automatically refresh in near real-time are
fundamental building blocks for the delivery of population health interventions.
“Population Health adopters averaged lower acute occupancy rates than nonadopters. Hospitals with 501+ beds that adopted population health average 36%
lower occupancy rates than non-adopters,” (FitzGerald, 2017)

Well implemented population health programs will underpin the success of the transition
to value-based care, and ultimately to the reduction of the burden of chronic disease.
However the current trajectory is challenged by high levels of complexity with regard to
patient diagnosis. To meet the demands of quality measures and regulatory reporting, a
move away from complex custom development to scalable, agile methods could provide
the best path forward. Kannan et al. (2017) were able to accelerate the deployment of
population registries using a finite set of core principles and a re-usable technology
toolkit. Although the development of accurate population health phenotypes will
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continue, perhaps an improved short-term solution would be to build population health
interventions based on a common treatment plans instead of a specific diagnosis.

Figure 14. Process drives outcome: transformation of individual care to population
impact (Sitapati, A. M., Berkovich B., 2017)

Recurring process cycles applied individuals are at the core of the population health
model as shown in Figure 14 Process drives outcome: transformation of individual care
to population impact. Chronic care treatment plans frequently follow similar patterns of
clinic visits, lab tests, and medication adjustments. When the right cohort receives the
right care, and achieves the right impact, the population effects reduce adverse events,
costs, and newly diagnosed cases. Population health interventions of the future may rely
more heavily on computer-based recommendations to assist clinicians in optimizing
complex long-term chronic care planning. Yet there are ample opportunities for
population health programs of today to effectively and efficiently deliver personalized
plans to benefit of the whole patient population.
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Appendix A: Literature Review Search Terms

Table 16. Literature search terms and results
Search

Intent

1 (("Heart Diseases"(Zheng, Yarzebski, Ramesh,
To identify a set of articles addressing the
Goldberg, & Yu) OR heart disease(Zwinderman et al.) treatment of Diabetes, Chronic Kidney
OR cardiovascular disease[tw]) OR
Disease, or Heart Disease
("Diabetes Mellitus"[Mesh] OR "Diabetes
Insipidus"[Mesh] OR Diabetes[tw]) OR ("Renal
Insufficiency, Chronic"[Mesh] OR chronic kidney
disease[tw])

Articles returned
1,594,280

2 "Quality Indicators, Health Care"[Mesh] OR
"value sets"[Title/Abstract] OR Quality
Indicators[Title/Abstract]

To identify a set of articles addressing
quality indicators for health care or “value
sets”

18,103

3 "Vocabulary, Controlled"[Mesh] OR "Systematized
Nomenclature of Medicine" OR "SNOMED" OR
"International Classification of Diseases" OR
Phenotype OR phenotyping

To identify a set of articles about use of a
controlled vocabulary like SNOMED or the
International Classification of Diseases for
phenotyping

458,707
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Search
4 ("Electronic Health Records"[Mesh] OR "Electronic
Health Record"[Text Word] OR Electronic Medical
Record [Text Word] OR "EPIC"[Text Word] OR
"Medical Records Systems, Computerized"[Mesh])

Intent

Articles returned

To identify a set of articles about Electronic
Health Records or alternate terms for EHRs

35,930

5 ("Vocabulary, Controlled"[Mesh] OR
To identify a set of articles about use of a
"Phenotype"[Mesh] OR
controlled vocabulary or Phenotype such as
"Systematized Nomenclature of Medicine" OR
SNOMED or ICD
"SNOMED" OR
"International Classification of Diseases" OR "ICD"
OR Phenotype OR phenotyping)

477,503

6 #1 AND #2 AND #3

Articles discussing Quality Indicators or Value
Sets for Phenotyping in SNOMED or
International Classification of Disease in the
setting of Heart Disease, Diabetes, or Chronic
Kidney Disease

34 publications

7 #1 AND #4 AND #5

Articles discussing Electronic Health Records
using or phenotyping or controlled vocabularies
like SNOMED or ICD the setting of Heart
Disease, Diabetes, or Chronic Kidney Disease

193 publications
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Appendix B: Electronic Phenotyping Evaluation Methods
Table 17. Methods used to evaluate electronic phenotypes (from literature search)

Statistical
Method

Coded Terminology
n=54

Text Mining
n=11

Sensitivity
25

Anderson 2016
Asao 2015
Bagheri 2009
Baker 2007
Broberg 2015
Coleman 2015
Ferris 2009
Floyd 2016
Fort 2014
Garvin 2013
Kleinberg 2013
Lawrence 2013
Liaw 2011
Navaneethan 2011
Onofrei 2004
Rosenman 2013
So 2006
Thiru 2003 AMIA
Symp
Thiru 2009
Udris 2001
Wei… Chute 2011
Zhong 2015

Brown &
Sonksen, 2000
Garvin 2013
Liao 2015
Murff 2011

2x2 contingency Garvin 2013
Kleinberg 2013
table
Lawrence 2013
9
Liaw 2011
Onofrei 2004
Wei… Chute 2011
Wilke 2007

Brown 2000
Nadkarni 2014
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Hybrid
n=5

Statistical
Method

Appendix B: Electronic Phenotyping studies (cont.)
Coded Terminology
Text Mining
Hybrid (both)

Specificity
18

Anderson 2016
Asao 2015
Broberg 2015
Coleman 2015
Ferris 2009
Floyd 2016
Fort 2014
Garvin 2013
Lawrence 2013
Liaw 2011
Navaneethan 2011
Onofrei 2004
So 2006
Udris 2001
Wei… Chute 2011
Zhong 2015

Liao 2015
Murff 2011

Recall
6

Lieberman 2003
Thiru 2003
Thiru 2009

Abhyankar 2014
Wei… Chute 2010
Zheng 2014

Precision
6

Lieberman 2003

Abhyankar 2014
Bromuri 2013
Wei… Chute 2010
Zheng 2014

Accuracy
6

Anderson 2016
Broberg 2015
Lawrence 2013
Liaw 2011
Udris 2001

Agarwal 2016

Agarwal 2016
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Appendix B: Electronic Phenotyping studies (cont.)

Statistical
Method

Coded
Terminology

PPV
29

Anderson 2016
Andrade 2011
Bagheri 2009
Bobo 2011
Borzecki
Coleman 2015
Ferris 2009
Floyd 2016
Fort 2014
Garvin 2013
Kleinberg 2013
Lawrence 2013
Liaw 2011
Navaneethan 2011
Onofrei 2004
Rosenman 2013
So 2006
Thiru 2003
Thiru 2009
Udris 2001
Wei… Chute 2011
Wei… Chute 2013
Wei…Denny 2015
Zhong 2015

NPV
10

Anderson 2016
Floyd 2016
Lawrence 2013
Liaw 2011
Navaneethan 2011
Onofrei 2004
So 2006
Udris 2001

Text Mining

Hybrid

Liao 2015
Nadkarni 2014
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Appendix B: Electronic Phenotyping studies (cont.)

Statistical
Method

Coded Terminology

AUC/ROC
5

Lawrence 2013
Thiru 2003
Thiru 2009
Wei…Denny 2015

Simple % match
2

Meyers 2011

Text Mining

Murff 2011

Hulse 2013

Odds Ratio
1

Liao 2015

Coverage
1

Predicted
Prevalence Ratio
1

Bromuri 2014

Asao 2015

Bayes theorem
1

Abhyankar 2014

Bromuri 2014

Hamming loss/
Ranking loss
1
Total
N=61 unique

Hybrid (both)

54

11

99
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Appendix C: Value Set Authority Center Downloads

Table 18. VSAC Value Sets for Diabetes, Chronic Kidney Disease, Stage 5, and Heart
Failure
Diabetes
OID

2.16.840.1.113883.3.464.1003.103.11.1001 Diabetes

ICD-9-CM

2.16.840.1.113883.3.464.1003.103.11.1002 Diabetes

ICD-10

2.16.840.1.113883.3.464.1003.103.11.1003 Diabetes

SNOMED

Chronic Kidney Disease, Stage 5

OID
2.16.840.1.113883.3.526.2.1035

Chronic Kidney
Disease, Stage 5

ICD-9-CM

2.16.840.1.113883.3.526.2.1036

Chronic Kidney
Disease, Stage 5

ICD-10-CM

2.16.840.1.113883.3.526.2.1037

Chronic Kidney
Disease, Stage 5

SNOMED CT

Heart Failure

OID
2.16.840.1.113883.3.526.2.23

Heart Failure

ICD-9-CM

2.16.840.1.113883.3.526.2.24

Heart Failure

ICD-10-CM

2.16.840.1.113883.3.526.2.25

Heart Failure

SNOMED CT
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Appendix D: Reference Standard for Diabetes

The Type 2 Diabetes Mellitus phenotype developed by the eMERGE network was used
as the reference standard with limited modifications (Pacheco, 2012). This research
phenotypes presented some challenges when applied to the context of population health
cohorts. It’s design as a research phenotype used positive and negative case selection
algorithms to find highly specific cases and controls in a sampling methodology.
Population health programs require that every patient in an active patient population be
included or excluded from a disease cohort. Detailed analysis of patient inclusion and
exclusion as it occurred for each rule revealed logic errors, missing or undetected data,
contradictory or ambiguous data, and the unavailability of standard LOINC (laboratory
codes). Table 19 eMerge diabetes reference standard findings N= 201,913 details the
numbers of patients selected for inclusion based on each of the five phenotype rules.
Each row of the table represents a rule. The phenotype algorithm identified 11,278
patients with diabetes in study population of 201,913. Of those, 914 patient had a
diagnosis of Type 2 diabetes and had taken Type 2 diabetes medications before starting
Type 1 diabetes medications. Another 6,619 patients had a diagnosis of Type 2 diabetes
and had taken Type 2 diabetes medications (with no evidence for Type 1 diabetes
medications). 1,483 patients had a diagnosis of Type 2 diabetes and abnormal diabetes
lab results. 1,129 patients had Type 2 diabetes medication and abnormal diabetes lab, but
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no diabetes diagnosis. 1,133 had a two or more Type 2 diabetes diagnosis and Type 1
diabetes medication (no evidence of Type 2 diabetes medication).

Table 19. eMerge diabetes reference standard findings N= 201,913
eMerge
Phenotype
Rule

Count
of
patients

Type 2
diabetes
DX

Type 1
diabetes
Med

Type 2
diabetes
Med

Type 2 Med
prescribed before
Type 1 Med

1

914

Yes

Yes

Yes

Yes

2

6,619

Yes

3

1,483

Yes

4

1,129

5

1,133

Total

11,278

Yes
Yes
Yes

Yes

Abnormal
diabetes
Labs

Yes

Yes

Logic errors
This algorithm requires that a type 2 diabetes diagnosis or medication is found in the
patient record before evaluating the diabetes labs (random glucose, fasting glucose or
Hemoglobin A1c). Further analysis of the study data revealed that 1385 patients excluded
from the Type 2 diabetes cohort had two A1C results greater than 6.5 at least 90 day
apart. The concept of persistence, i.e. abnormal test results that persist over a period of
time can be used in phenotyping to reduce the likelihood that a test results was reported
in error or is related to a temporary condition that would not benefit from chronic care
management.
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Therefore, phenotype algorithms that make diagnoses a precondition for evaluating
laboratory test may be inadvertently excluding true diabetics. Since diabetic patients
receiving effective treatment may have normal glucose and A1c lab results, it may also
be overly restrictive for a diabetes phenotype algorithm to require abnormal lab results
before searching for a diabetes diagnosis or medications.
Missing or undetected data
In the operationalization of the diabetes reference standard phenotype, the problem list,
and ambulatory encounter diagnoses were searched for matching diagnosis codes. There
are a number of other locations within the electronic health record where diagnosis data is
stored. Discrete diagnosis data is also captured as medical history, inpatient diagnoses,
billed diagnoses. Free-text clinical notes have diagnosis information that is largely
inaccessible to rule-based algorithms that depend on discrete data.
Contradictory or ambiguous data
Of the 1,385 patients had persistent abnormal A1c (two labs greater than 6.5 over a
period greater than 90 days). Further analysis of the data revealed that 715 patients had
both Type 1 and Type 2 diabetes definitions. Of those 209 had only a single Type 1
diagnosis and Type 2 diagnosis counts ranging from 1-82.
Challenges with the implementation of LOINC laboratory codes
The eMERGE algorithm specified LOINC terminology codes to identify labs used for
diabetic patients. Since lab results in the test EHR did not uniformly capture LOINC
codes, local laboratory codes were substituted. This demonstrates that although certified
EHR systems must support LOINC standards, the implementation of interfaces and
workflows to capture this data may not be implemented at the local level. Table 20 Local
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diabetes lab result component names used in lieu of LOINC codes details the local names
used for each component.
Table 19. Local diabetes lab result component names used in lieu of LOINC codes
Laboratory Test

Component Name

Hemoglobin A1C

Glyco HG (A1C)
HEMOGLOBIN A1C-MEDCOM
HEMOGLOBIN A1C-QUEST
HEMOGLOBIN A1C-LABCORP
HEMOGLOBIN A1C (POCT)
HEMOGLOBIN A1C / HEMOGLOBIN TOTAL –LABCORP

Glucose

GLUCOSE
GLUCOSE (POCT)
GLUCOSE-QUEST
GLUCOSE-LABCORP

Fasting glucose

GLUCOSE, FASTING -LABCORP
GTT FASTING-QUEST
GTT 0-MIN
GTT 30-MIN
GTT 1-HOUR
GTT 2-HOUR
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Appendix E: Recommendations for Population Health Programs

Table 21. Recommendations for population health programs
Observation

1 Current versions of national
value sets for diagnosis cohorts
were not designed for, and may
not be sufficiently accurate to
drive clinical interventions.
Quality dashboards for
clinicians are being developed
in parallel with quality
dashboards for reporting.

2 EHR systems that use
terminology vendors to map
local codes and proprietary
terms to ICD-9, ICD-10 and
SNOMED are widely used.
VSAC chronic disease value
sets that are purportedly
synonymous may have
significant variation based on
the choice of ICD or SNOMED
terminology. There was little
variation between ICD-9 and
ICD-10 value sets in the
conditions tested.

Recommendation

Goal

The value set model should
be expanded to a phenotype
model. Population health
programs need to look
beyond readily available
diagnosis codes to deliver
patient cohort definitions
designed for actionable
interventions.

National phenotypes
will increase the
efficiency of population
health programs by
sharing the burden for
phenotype development
for clinical
interventions and
quality reporting

ICD should be the preferred
diagnosis coding
terminology for the retrieval
of population health cohorts
in national value sets.

A clinically relevant
and consistent set of
national value sets and
phenotype rules will
improve the accuracy
and consistency of
The hierarchical structure of reported quality
the SNOMED concepts,
measures
coupled with the low
interrater reliability for
NOTE: This
SNOMED coding combine recommendation would
to make the retrieval of
not apply to EHR
SNOMED cohorts more
systems that apply
subject to unanticipated
diagnoses in Native
variability.
SNOMED CT

105

Table 21. Recommendations for population health programs (cont.)
Observation

Recommendation

Goal

3 VSAC value sets are published
without any quantitative
measurement or rating of
performance

STARD (Standards for
Reporting Diagnostic
Accuracy) should inform
the essential list of items to
report in a study of
population health value sets
and phenotypes.

Reporting standards for
population phenotype
studies will facilitate
comparisons between
different approaches.

4 Although the focus on
population health programs is
often centered on the
technology, the social aspects of
system development
implementation and
measurement apply

Multidisciplinary teams
improve the likelihood of
success for population
health programs.

ROI on population
health IT will be
increase with the use of
good implementation
and monitoring
processes

5 Use of existing standards such
as LOINC and RXNORM are
not fully implemented and new
standards such as visit types,
common definitions of active
patients, outcomes such as
hemorraghic events are needed.

Quality programs should
increase demands for the
use of standard
terminologies in quality
reporting.

Health system
interoperability and the
foundations of the
Learning Health system
require the use of
standardized
terminologies.

Where national value sets
are not yet mandated, the
reporting of value sets used
in report cohorts would
provide a valuable raw data
set with which to inform
future phenotype research
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